{"content":"<li class=\"n-box-item date-title\" data-end=\"1488344399\" data-start=\"1488258000\" data-txt=\"Sunday, December 22, 2019\">Tuesday, February 28, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3247466\" data-ts=\"1488337358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSW\" target=\"_blank\">SSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247466-seaspan-beats-0_03-revenues-in-line-cuts-dividend-67\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seaspan beats by $0.03, revenues in-line, cuts dividend by 67%</a></h4><ul><li>Seaspan (NYSE:<a href='https://seekingalpha.com/symbol/SSW' title='Seaspan Corporation'>SSW</a>) Q4 EPS of $0.21 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $213.2M (+2.2%&nbsp;Y/Y) in-line.</li><li>Reduces quarterly dividend to $0.125 from $0.375.</li><li>SSW -<font color='red'>11.7%</font>&nbsp;AH.</li><li><a href=\"https://seekingalpha.com/pr/16757006-seaspan-reports-financial-results-quarter-year-ended-december-31-2016\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247466\" data-linked=\"Seaspan beats by $0.03, revenues in-line, cuts dividend by 67%\" data-tweet=\"$SSW - Seaspan beats by $0.03, revenues in-line, cuts dividend by 67% https://seekingalpha.com/news/3247466-seaspan-beats-0_03-revenues-in-line-cuts-dividend-67?source=tweet\" data-url=\"https://seekingalpha.com/news/3247466-seaspan-beats-0_03-revenues-in-line-cuts-dividend-67\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247462\" data-ts=\"1488333409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFR\" target=\"_blank\">SFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247462-colony-starwoodminus-1_4-on-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colony Starwood -1.4% on share sale</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16756862-colony-starwood-homes-announces-public-offering-common-shares\" target=\"_blank\">offering size is 18.5M shares</a>, of which 10.5M are being offered by certain selling shareholders, and the rest by the company. The underwriters have greenshoe options for about another 2.8M shares.</li><li><a href='https://seekingalpha.com/symbol/SFR' title='Starwood Waypoint Homes Inc'>SFR</a><font color='red'> -1.4%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247462\" data-linked=\"Colony Starwood -1.4% on share sale\" data-tweet=\"$SFR - Colony Starwood -1.4% on share sale https://seekingalpha.com/news/3247462-colony-starwoodminus-1_4-on-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3247462-colony-starwoodminus-1_4-on-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247457\" data-ts=\"1488327811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247457-fda-to-review-dynavaxs-responses-to-heplisav-b-crl-action-date-august-10-shares-ahead-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA to review Dynavax&#39;s responses to HEPLISAV-B CRL, action date August 10; shares ahead 27% after hours</a></h4><ul><li>Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) is up&nbsp;<font color='green'>27%&nbsp;</font>after hours on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16756618-dynavax-announces-fda-acceptance-review-complete-response-november-2016-crl-pdufa-action-date\" target=\"_blank\">announcement </a>that the FDA has accepted for review its responses to the Complete Response Letter &#40;CRL&#41; it received last November regarding its Biologics License Application &#40;BLA&#41; for HEPLISAV-B. The agency's action date is August 10.</li><li>The CRL requested clarification regarding specific adverse events of special interest (AESIs) and a numerical imbalance in a small number of cardiac events in the HBV-23 study. It also cited the need for new analyses of the integrated safety database across different time periods and post-marketing commitments.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3224130-fda-rejects-dynavaxs-heplisav-b-marketing-application-shares-plummet-74-percent-premarket\" target=\"_blank\">FDA rejects Dynavax's HEPLISAV-B marketing application; shares plummet 74% premarket</a> (Nov. 14, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247457\" data-linked=\"FDA to review Dynavax&#39;s responses to HEPLISAV-B CRL, action date August 10; shares ahead 27% after hours\" data-tweet=\"$DVAX - FDA to review Dynavax&#39;s responses to HEPLISAV-B CRL, action date August 10; shares ahead 27% after hours https://seekingalpha.com/news/3247457-fda-to-review-dynavaxs-responses-to-heplisav-b-crl-action-date-august-10-shares-ahead-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3247457-fda-to-review-dynavaxs-responses-to-heplisav-b-crl-action-date-august-10-shares-ahead-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247452\" data-ts=\"1488325797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TV\" target=\"_blank\">TV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247452-grupo-televisaminus-4_8-after-ruling-sets-up-tougher-regulation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grupo Televisa -4.8% after ruling sets up tougher regulation</a></h4><ul>   <li>Grupo Televisa (NYSE:<a href='https://seekingalpha.com/symbol/TV' title='Grupo Televisa, S.A.'>TV</a>) <font color='red'>dropped 4.8%</font> after a regulator reversed course on a 2015 ruling and decided that Televisa <a href=\"http://uk.reuters.com/article/televisa-stocks-idUKL2N1GD1A8\" target=\"_blank\">does have market power</a> in pay television.</li>    <li>That move sets up the prospect of tougher regulation. Last month, a Mexican tribunal <a href=\"https://seekingalpha.com/news/3236291-tribunal-strikes-telecom-ruling-favorable-grupo-televisa\" target=\"_blank\">threw out a ruling</a> that said Televisa didn't have market power, forcing the Federal Telecommunications Institute to take up the matter again.</li>    <li>The IFT now says Televisa, the country's largest pay TV provider with about 60% of all subscribers, has \"substantial market power.\"</li>    <li>The move brought Televisa off its highest point since last September (shares closed at $26.79 yesterday, and finished at $25.51 today).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247452\" data-linked=\"Grupo Televisa -4.8% after ruling sets up tougher regulation\" data-tweet=\"$TV - Grupo Televisa -4.8% after ruling sets up tougher regulation https://seekingalpha.com/news/3247452-grupo-televisaminus-4_8-after-ruling-sets-up-tougher-regulation?source=tweet\" data-url=\"https://seekingalpha.com/news/3247452-grupo-televisaminus-4_8-after-ruling-sets-up-tougher-regulation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247447\" data-ts=\"1488324003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247447-intel-downgraded-to-underperform-bernstein\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel downgraded to Underperform at Bernstein</a></h4><ul><li>From Market Perform, <a href=\"http://blogs.barrons.com/techtraderdaily/2017/02/28/intel-sell-says-bernstein-server-is-cracking-fabs-aint-what-they-once-were/\" target=\"_blank\">analyst Stacy Rasgon</a> notes competitive challenges, signals datacenter is \"cracking,\"&nbsp;pressured margins due to heightened investments, expensive valuation (considers \"ripe for re-rating\") and declining opportunities for growth and advantages in process.</li><li>Price target from $36 to $30. Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) $35.79,&nbsp;<font color='red'>-1.13%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247447\" data-linked=\"Intel downgraded to Underperform at Bernstein\" data-tweet=\"$INTC - Intel downgraded to Underperform at Bernstein https://seekingalpha.com/news/3247447-intel-downgraded-to-underperform-bernstein?source=tweet\" data-url=\"https://seekingalpha.com/news/3247447-intel-downgraded-to-underperform-bernstein\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247445\" data-ts=\"1488323828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247445-fox-to-create-single-app-to-stream-networks-programming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox to create single app to stream its networks&#39; programming</a></h4><ul>   <li>Twenty-First Century Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-1.7%</font>) plans to <a href=\"http://www.broadcastingcable.com/news/currency/fox-planning-new-video-streaming-app-combining-networks/163681\" target=\"_blank\">build a single app</a> that will unify online programming access across its American networks, including such channels as Fox, National Geographic and FX.</li>    <li>That means one sign-on rather than many, simplifying the process, Chairman Lachlan Murdoch told a Morgan Stanley investor conference.</li>    <li>A single app also has the benefit of giving the company more information about viewers, he said: &ldquo;The more data we have on our customers, the better we are at having the capability to monetize through advertising to those consumers,\" noting that monetizing nonlinear viewing is up 30% with the help of better data usage.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247445\" data-linked=\"Fox to create single app to stream its networks&#39; programming\" data-tweet=\"$FOX $FOX $FOXA - Fox to create single app to stream its networks&#39; programming https://seekingalpha.com/news/3247445-fox-to-create-single-app-to-stream-networks-programming?source=tweet\" data-url=\"https://seekingalpha.com/news/3247445-fox-to-create-single-app-to-stream-networks-programming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247439\" data-ts=\"1488322136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENPH\" target=\"_blank\">ENPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247439-enphase-energyminus-20-after-missing-q4-guiding-q1-revenues-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enphase Energy -20% after missing Q4, guiding Q1 revenues below consensus</a></h4><ul>     <li>Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a>)&nbsp;<font color='red'>-20.1%</font>&nbsp;AH after reporting a larger than expected <a href=\"https://seekingalpha.com/news/3247349-enphase-energy-misses-0_03-misses-revenue\" target=\"_blank\">Q4 loss</a> and issuing downside guidance for Q1, seeing revenues of $60M-$65M vs. $73M analyst consensus estimate.</li><li>During Q4, ENPH says it sold 194 MW, or 815K   microinverters; Q4 GAAP gross margin was  17.9%, and non-GAAP gross margin was 18.2%; ENPH expects Q1 GAAP and non-GAAP gross margin to come in at 16%-20%.</li><li>ENPH says it took incremental restructuring actions in Q1 2017,  which it expects to result in an additional $18M of  annualized non-GAAP operating expense savings starting in Q2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247439\" data-linked=\"Enphase Energy -20% after missing Q4, guiding Q1 revenues below consensus\" data-tweet=\"$ENPH - Enphase Energy -20% after missing Q4, guiding Q1 revenues below consensus https://seekingalpha.com/news/3247439-enphase-energyminus-20-after-missing-q4-guiding-q1-revenues-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3247439-enphase-energyminus-20-after-missing-q4-guiding-q1-revenues-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247435\" data-ts=\"1488321683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247435-ambarellaminus-5-q4-2017-over-estimates-revenue-outlook-off-75m-buyback-authorized\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella -5%; Q4 2017 over estimates with revenue outlook off, $75M buyback authorized</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3247311-ambarella-beats-0_18-beats-revenue\" target=\"_blank\">Q4 2017 results</a></strong> &ndash; revenue $87.5M (+28.7% Y/Y,&nbsp;<font color='green'>$1.43M above estimates</font>), EPS $0.92 (<font color='green'>$0.18 above estimates</font>), gross margin 67.2% (vs. 64.1% Y/Y), net income $32M (vs. $21.6M Y/Y)</li><li><strong>Other developments</strong> &ndash; Authorizes $75M share repurchase.</li><li><strong>Q1 2018 projections</strong> &ndash; revenue $62.5M-$64.5M (<a href=\"https://finance.yahoo.com/quote/AMBA/analysts?p=AMBA\" target=\"_blank\">consensus $69.61M</a>), gross margin 63%-64.5%, operating expenses $26M-$27.5M</li><li>Ambarella president and CEO Fermi Wang: \"During the year we continued to make progress in diversifying our markets and customer base and enjoyed significant revenue growth from home monitoring and drone markets, as well as building customer momentum in new OEM automotive applications. We entered mass production with our first 14nm SoCs, continued to raise the performance bar with the launch of our 4Kp60 Ultra HD SoCs and introduced our first automotive qualified solutions. Looking forward, we will continue to invest in computer vision technology, automotive solutions, and advanced 10nm process nodes, as we believe these efforts will provide significant additional opportunities for success in the future.\"</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>) $56</li><li><a href=\"https://seekingalpha.com/pr/16756685-ambarella-inc-announces-fourth-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press release</a> / <a href=\"http://edge.media-server.com/m/p/phoz76sx\" target=\"_blank\">conference call</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247435\" data-linked=\"Ambarella -5%; Q4 2017 over estimates with revenue outlook off, $75M buyback authorized\" data-tweet=\"$AMBA - Ambarella -5%; Q4 2017 over estimates with revenue outlook off, $75M buyback authorized https://seekingalpha.com/news/3247435-ambarellaminus-5-q4-2017-over-estimates-revenue-outlook-off-75m-buyback-authorized?source=tweet\" data-url=\"https://seekingalpha.com/news/3247435-ambarellaminus-5-q4-2017-over-estimates-revenue-outlook-off-75m-buyback-authorized\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247434\" data-ts=\"1488321481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247434-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='green'>+14.5%</font>. <a href='https://seekingalpha.com/symbol/DAR' title='Darling Ingredients Inc.'>DAR</a> <font color='green'>+6.8%</font>. <a href='https://seekingalpha.com/symbol/ORA' title='Ormat Technologies, Inc.'>ORA</a> <font color='green'>+5.0%</font>. <a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a> <font color='green'>+4.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='red'>-18.2%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-14.8%</font>. <a href='https://seekingalpha.com/symbol/EVHC' title='Envision Healthcare Holdings'>EVHC</a> <font color='red'>-12.1%</font>. <a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a> <font color='red'>-10.6%</font>. <a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a> <font color='red'>-6.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247434\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$BGFV $DAR $ORA - After Hours Gainers / Losers https://seekingalpha.com/news/3247434-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3247434-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247413\" data-ts=\"1488319318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247413-salesforceminus-1_66-q4-2017-over-expectations-q1-outlook-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce -1.66%; Q4 2017 over expectations, Q1 outlook light</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3247340-salesforce-com-beats-0_03-beats-revenue\" target=\"_blank\">Q4 2017 results</a></strong> &ndash; revenue $2.29B (+26.5% Y/Y,&nbsp;<font color='green'>$10M above estimates</font>), EPS $0.28 (<font color='green'>$0.03 above estimates</font>), operating cash flow $706M (+50% Y/Y), deferred revenue $5.54B (+29% Y/Y), unbilled deferred revenue $9B (+27% Y/Y)</li><li><strong>Q1 2018 projections</strong> &ndash; revenue $2.34B-$2.35B (+22%-23% Y/Y; <a href=\"https://finance.yahoo.com/quote/CRM/analysts?p=CRM\" target=\"_blank\">consensus $2.37B</a>), EPS $0.25-$0.26 (consensus $0.30), deferred revenue +22%-23% Y/Y</li><li><strong>FY 2018 projections</strong> &ndash; revenue $10.15B-$10.2B (+21%-22% Y/Y; consensus $10.15B), EPS $1.27-$1.29 (consensus $1.28), operating cash flow +20%-21% Y/Y</li><li>Salesforce chairman and CEO Marc Benioff: \"Salesforce continues to deliver incredible innovation and unprecedented customer success. We led the industry as the first to bring cloud, social and mobile to CRM, and now with our latest release we are making artificial intelligence available to millions of Salesforce users with Einstein.\"</li><li><strong>After hours</strong> &ndash; (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) $80</li><li><a href=\"https://seekingalpha.com/pr/16756665-salesforce-announces-fiscal-2017-fourth-quarter-full-year-results\" target=\"_blank\">Press release</a> / <a href=\"http://edge.media-server.com/m/p/tonao55m\" target=\"_blank\">conference call</a> / <a href=\"http://investor.salesforce.com/files/doc_financials/2017/Q4/CRM-Q4-FY17-Earnings-Presentation.pdf\" target=\"_blank\">summary deck</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247413\" data-linked=\"Salesforce -1.66%; Q4 2017 over expectations, Q1 outlook light\" data-tweet=\"$CRM - Salesforce -1.66%; Q4 2017 over expectations, Q1 outlook light https://seekingalpha.com/news/3247413-salesforceminus-1_66-q4-2017-over-expectations-q1-outlook-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3247413-salesforceminus-1_66-q4-2017-over-expectations-q1-outlook-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247407\" data-ts=\"1488319055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247407-acadia-pharma-edges-lower-after-sales-top-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharma edges lower after sales top estimates</a></h4><ul><li>Q4 net product sales of $12M topped estimates by nearly $3M.</li><li>R&amp;D expense of $30.2M vs. $20.5M a year ago; SG&amp;A expense of $57.7M vs. $22.6 thanks to the sales force and costs from NUPLAZID.</li><li>Cash and cash equivalents on hand as of Dec. 31 of $529M vs. $215.1M a year earlier.</li><li><a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.acadia-pharm.com&amp;esheet=51517489&amp;newsitemid=20170228006733&amp;lan=en-US&amp;anchor=www.acadia-pharm.com&amp;index=1&amp;md5=3506e914acc18f2b1821104f4fdc28ad\" target=\"_blank\">Conference call</a> starts at 5 ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247319-acadia-pharma-eps-line-beats-revenue\" target=\"_blank\">ACADIA Pharma EPS in-line, beats on revenue</a> (Feb. 28)</li><li><a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>&nbsp;<font color='red'>-0.3%</font>&nbsp;in active after hours action.</li><li>SA Contributor George Rho has published an <a href=\"https://seekingalpha.com/article/2522985-acadia-still-offers-considerable-upside-potential#comment-74477033\" target=\"_blank\">informative article</a> on the company. He believes the stock still has plenty of upside.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247407\" data-linked=\"Acadia Pharma edges lower after sales top estimates\" data-tweet=\"$ACAD - Acadia Pharma edges lower after sales top estimates https://seekingalpha.com/news/3247407-acadia-pharma-edges-lower-after-sales-top-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3247407-acadia-pharma-edges-lower-after-sales-top-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247399\" data-ts=\"1488318593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247399-harmonic-beats-in-q4-revenues-jump-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic beats in Q4 as revenues jump 30%</a></h4><ul>   <li>Harmonic (<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a> <font color='red'>-1.8%</font>) has posted <a href=\"https://seekingalpha.com/news/3247325-harmonic-beats-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a> that beat expectations after revenues rose more than 30%.</li>    <li>Net revenue on a non-GAAP basis rose to $113.8M, which was also up 11.9% sequentially. Bookings for Q4 were $116.9M, up 15.7% Y/Y.</li>    <li>Net loss narrowed on a GAAP basis to $10.4M. Non-GAAP net income rose to $6.7M from a year-ago $0.6M.</li>    <li>Revenue breakout: Product, $79.9M (up 29.5%); Service, $33.2M (up 33.3%). Among product revenues: Video products, $75.2M; Cable Edge, $4.8M.</li>    <li>Cash and equivalents came to $62.6M, up $9.9M Q/Q.</li>    <li>For Q1, the company's guiding (on a non-GAAP basis) to net revenue of $87M-$95M (light of expectations for $96.9M), gross margin of 53-54%, and EPS of -$0.08 to -$0.04.</li>    <li>Shares are back to flat in very choppy after-hours trading so far.</li>    <li><a href=\"http://www.harmonicinc.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16756715-harmonic-announces-fourth-quarter-fiscal-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247399\" data-linked=\"Harmonic beats in Q4 as revenues jump 30%\" data-tweet=\"$HLIT - Harmonic beats in Q4 as revenues jump 30% https://seekingalpha.com/news/3247399-harmonic-beats-in-q4-revenues-jump-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3247399-harmonic-beats-in-q4-revenues-jump-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247385\" data-ts=\"1488317727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247385-weight-watchers-pops-after-earnings-satisfy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers pops after earnings satisfy</a></h4><ul><li>Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) skyrockets after the company tops estimates with its Q4 report.</li><li>Total paid weeks were up 10% during the quarter. Subscriber count also grew by 10%.</li><li>The company expects FY17 EPS of $1.30 to $1.40 to top the consensus estimate.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247342-weight-watchers-beats-0_02-misses-revenue\" target=\"_blank\">Weight Watchers beats by $0.02, misses on revenue</a> (Feb. 28)</li><li>WTW&nbsp;<font color='green'>+11.33%</font>&nbsp;AH to $15.95. Shares were up over 21% during the session at one point.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247385\" data-linked=\"Weight Watchers pops after earnings satisfy\" data-tweet=\"$WTW $WW - Weight Watchers pops after earnings satisfy https://seekingalpha.com/news/3247385-weight-watchers-pops-after-earnings-satisfy?source=tweet\" data-url=\"https://seekingalpha.com/news/3247385-weight-watchers-pops-after-earnings-satisfy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247382\" data-ts=\"1488317698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247382-sareptaminus-2-after-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta -2% after Q4 results</a></h4><ul><li>Q4 non-GAAP net loss of $38.7M or $0.71 per share vs. loss of $58.3M and $1.30 one year ago.</li><li>Revenue of $5.4M recognized for EXONDYS 51 in Q4.</li><li>Non-GAAP R&amp;D expense of $27.8M vs. $38.6M a year earlier. Non-GAAP SG&amp;A expense of $16.1M vs. $20.7M.</li><li>Cash on hand of $329.3M vs. $204M a year ago, helped by two capital raises in 2016.</li><li><a href=\"http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&amp;p=irol-calendar\" target=\"_blank\">Conference call</a> is getting underway now.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247314-sarepta-therapeutics-beats-0_62-beats-revenue\" target=\"_blank\">Sarepta Therapeutics beats by $0.62, beats on revenue</a> (Feb. 28)</li><li><a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a><font color='red'> -2%&nbsp;</font>after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3247382\" data-linked=\"Sarepta -2% after Q4 results\" data-tweet=\"$SRPT - Sarepta -2% after Q4 results https://seekingalpha.com/news/3247382-sareptaminus-2-after-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3247382-sareptaminus-2-after-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247373\" data-ts=\"1488317570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALR\" target=\"_blank\">ALR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247373-alere-informs-abbott-of-new-issue-in-asia-shares-off-4-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alere informs Abbott of a &quot;new issue&quot; in Asia; shares off 4% today</a></h4><ul><li>Alere (NYSE:<a href='https://seekingalpha.com/symbol/ALR' title='Alere Inc.'>ALR</a>) slumped&nbsp;<font color='red'>4%</font>&nbsp;in the regular session a 70% spike in volume. Bloomberg reported that, in mid-February, it informed acquirer Abbott (NYSE:<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a>) about a \"new issue\" in Asia, a day or two after it informed its own audit committee about the matter.</li><li>Alere says any notion that it is hiding information or not making disclosure is \"completely contrary to the facts.\"</li><li>Abbott first announced its $5.8B takeover of Alere about a year ago, but has since tried to back out of the deal due to negative revelations about Alere's business practices, inappropriate revenue recognition and a government inquiry into its marketing and billing practices.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3229161-abbott-back-alere-deal\" target=\"_blank\">Abbott to back out of Alere deal</a> (Dec. 7, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247373\" data-linked=\"Alere informs Abbott of a &quot;new issue&quot; in Asia; shares off 4% today\" data-tweet=\"$ALR $ALR $ABT - Alere informs Abbott of a &quot;new issue&quot; in Asia; shares off 4% today https://seekingalpha.com/news/3247373-alere-informs-abbott-of-new-issue-in-asia-shares-off-4-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3247373-alere-informs-abbott-of-new-issue-in-asia-shares-off-4-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247332\" data-ts=\"1488317388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247332-palo-alto-networksminus-14_6-q2-2017-revenue-and-outlook-off-lightcyber-acquired-500m-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks -14.6%; Q2 2017 revenue and outlook off, LightCyber acquired, $500M buyback authorized</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3247308-palo-alto-networks-beats-0_01-misses-revenue\" target=\"_blank\">Q2 2017 results</a></strong> &ndash; revenue $422.6M (+26.3% Y/Y,&nbsp;<font color='red'>$7.12M below estimates</font>), EPS $0.63 (<font color='green'>$0.01 above estimates</font>), billings $561.6M (+22% Y/Y), deferred revenue $1.5B (+61% Y/Y), net income $59.6M (vs. $39.5M Y/Y), cash flow from operations $214.3M (+39% Y/Y), free cash flow $169.6M (+24% Y/Y)</li><li><strong>Other developments</strong> &ndash; Acquires <a href=\"https://seekingalpha.com/pr/16756712-palo-alto-networks-completes-acquisition-lightcyber\" target=\"_blank\">LightCyber for $105M</a>&nbsp;cash,&nbsp;authorizes $500M share repurchase (marks total authorization at $1B).</li><li><strong>Q3 2017 projections</strong> &ndash; revenue $406M-$416M (+17%-20%; <a href=\"https://finance.yahoo.com/quote/PANW/analysts?p=PANW\" target=\"_blank\">consensus $454.63M</a>), EPS $0.54-$0.56 (consensus $0.70)</li><li>Palo Alto Networks CEO Mark McLaughlin: \"While fiscal second quarter revenue of $423 million was yet another record for the company, we were disappointed that we came in below top-line expectations due to some execution challenges, which we are moving quickly to address. Our customers rely on us to solve their most difficult cybersecurity challenges, and we have yet again widened the technology gap between our Next-Generation Security Platform and the competition with the largest product and features launch in our history, including expansion of our virtual and cloud capabilities. We are also extending our capabilities in data analytics and machine learning with today's announcement of our acquisition of LightCyber.\"</li><li><strong>After hours</strong> &ndash; (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) $129.75</li><li><a href=\"https://seekingalpha.com/pr/16756698-palo-alto-networks-reports-fiscal-second-quarter-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;/ <a href=\"http://edge.media-server.com/m/p/44q8ahv2/lan/en\" target=\"_blank\">conference call</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247332\" data-linked=\"Palo Alto Networks -14.6%; Q2 2017 revenue and outlook off, LightCyber acquired, $500M buyback authorized\" data-tweet=\"$PANW - Palo Alto Networks -14.6%; Q2 2017 revenue and outlook off, LightCyber acquired, $500M buyback authorized https://seekingalpha.com/news/3247332-palo-alto-networksminus-14_6-q2-2017-revenue-and-outlook-off-lightcyber-acquired-500m-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3247332-palo-alto-networksminus-14_6-q2-2017-revenue-and-outlook-off-lightcyber-acquired-500m-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247362\" data-ts=\"1488317260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247362-sales-hold-up-just-fine-ross-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sales hold up just fine at Ross Stores</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>) reports comparable sales rose 4% in <a href=\"https://seekingalpha.com/pr/16756615-ross-stores-reports-fourth-quarter-fiscal-2016-results\" target=\"_blank\">Q4</a> to top the expectation for a 2.8% rise.</li><li>The extra sales leverage helped Ross improve its operating margin rate by 90 bps to 13.6%.</li><li>The company's board approved a plan to buy back $1.75B worth of shares over two years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247292-ross-stores-beats-0_02-beats-revenue\" target=\"_blank\">Ross Stores beats by $0.02, beats on revenue</a> (Feb. 28)</li><li>ROST&nbsp;<font color='red'>-1.43%</font>&nbsp;AH to $67.60.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247362\" data-linked=\"Sales hold up just fine at Ross Stores\" data-tweet=\"$ROST - Sales hold up just fine at Ross Stores https://seekingalpha.com/news/3247362-sales-hold-up-just-fine-ross-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3247362-sales-hold-up-just-fine-ross-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247342\" data-ts=\"1488316682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247342-weight-watchers-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers beats by $0.02, misses on revenue</a></h4><ul><li>Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>): Q4 EPS of $0.20 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $267.4M (+3.2% Y/Y) <font color='red'>misses by $6.8M</font>.</li><li>Shares <font color='green'>+4.73%</font>.</li><li><a href='https://seekingalpha.com/pr/16756738-weight-watchers-announces-fourth-quarter-full-year-2016-results-provides-full-year-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247342\" data-linked=\"Weight Watchers beats by $0.02, misses on revenue\" data-tweet=\"$WTW $WW - Weight Watchers beats by $0.02, misses on revenue https://seekingalpha.com/news/3247342-weight-watchers-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3247342-weight-watchers-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247323\" data-ts=\"1488316315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247323-portola-pharmaceuticals-beats-0_17-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Pharmaceuticals beats by $0.17, beats on revenue</a></h4><ul><li>Portola Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>): Q4 EPS of -$0.95 <font color='green'>beats by $0.17</font>.</li><li>Revenue of $13.7M (+210.7% Y/Y) <font color='green'>beats by $9.72M</font>.</li><li>Shares <font color='green'>+1.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16756700-portola-pharmaceuticals-reports-fourth-quarter-year-end-2016-financial-results-provides'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247323\" data-linked=\"Portola Pharmaceuticals beats by $0.17, beats on revenue\" data-tweet=\"$PTLA - Portola Pharmaceuticals beats by $0.17, beats on revenue https://seekingalpha.com/news/3247323-portola-pharmaceuticals-beats-0_17-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3247323-portola-pharmaceuticals-beats-0_17-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247319\" data-ts=\"1488316212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247319-acadia-pharma-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACADIA Pharma EPS in-line, beats on revenue</a></h4><ul><li>ACADIA Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>): Q4 EPS of -$0.65 in-line.</li><li>Revenue of $12M <font color='green'>beats by $2.95M</font>.</li><li>Shares <font color='green'>+1.68%</font>.</li><li><a href='https://seekingalpha.com/pr/16756655-acadia-pharmaceuticals-reports-financial-results-fourth-quarter-year-ended-december-31-2016'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247319\" data-linked=\"ACADIA Pharma EPS in-line, beats on revenue\" data-tweet=\"$ACAD - ACADIA Pharma EPS in-line, beats on revenue https://seekingalpha.com/news/3247319-acadia-pharma-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3247319-acadia-pharma-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247305\" data-ts=\"1488315963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247305-fda-oks-lexicon-pharmas-telotristat-etiprate-for-carcinoid-syndrome\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Lexicon Pharma&#39;s telotristat etiprate for carcinoid syndrome</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16756597-fda-approves-lexicon-drug-xermelo-telotristat-ethyl-250-mg-first-oral-treatment-carcinoid\" target=\"_blank\">approves </a>Lexicon Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) XERMELO (telotristat ethyl) 250 mg for the treatment of carcinoid syndrome diarrhea, in combination with somatostatin therapy &#40;SSA&#41; in adult patients inadequately controlled with SSA therapy.</li><li>Carcinoid syndrome is a rare condition that affects people with metastatic neuroendocrine tumors (mNETs).</li><li>XERMELO targets the overproduction of serotonin inside mNET cells. It will be available in select specialty pharmacies beginning March 6.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>8%</font>&nbsp;after hours on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247305\" data-linked=\"FDA OKs Lexicon Pharma&#39;s telotristat etiprate for carcinoid syndrome\" data-tweet=\"$LXRX - FDA OKs Lexicon Pharma&#39;s telotristat etiprate for carcinoid syndrome https://seekingalpha.com/news/3247305-fda-oks-lexicon-pharmas-telotristat-etiprate-for-carcinoid-syndrome?source=tweet\" data-url=\"https://seekingalpha.com/news/3247305-fda-oks-lexicon-pharmas-telotristat-etiprate-for-carcinoid-syndrome\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247296\" data-ts=\"1488315829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGFV\" target=\"_blank\">BGFV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247296-big-5-sporting-goods-beats-0_02-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big 5 Sporting Goods beats by $0.02,  revenue in-line</a></h4><ul><li>Big 5 Sporting Goods (NASDAQ:<a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a>): Q4 EPS of $0.33 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $266.28M (-3.2% Y/Y) in-line.</li><li>Shares <font color='green'>+2.23%</font>.</li><li><a href='https://seekingalpha.com/pr/16756639-big-5-sporting-goods-corporation-announces-fiscal-2016-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247296\" data-linked=\"Big 5 Sporting Goods beats by $0.02,  revenue in-line\" data-tweet=\"$BGFV - Big 5 Sporting Goods beats by $0.02, revenue in-line https://seekingalpha.com/news/3247296-big-5-sporting-goods-beats-0_02-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3247296-big-5-sporting-goods-beats-0_02-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247292\" data-ts=\"1488315741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247292-ross-stores-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores beats by $0.02, beats on revenue</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>): Q4 EPS of $0.77 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $3.51B (+8.0% Y/Y) <font color='green'>beats by $50M</font>.</li><li>Shares <font color='green'>+2.07%</font>.</li><li><a href='https://seekingalpha.com/pr/16756615-ross-stores-reports-fourth-quarter-fiscal-2016-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247292\" data-linked=\"Ross Stores beats by $0.02, beats on revenue\" data-tweet=\"$ROST - Ross Stores beats by $0.02, beats on revenue https://seekingalpha.com/news/3247292-ross-stores-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3247292-ross-stores-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247286\" data-ts=\"1488315577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXST\" target=\"_blank\">NXST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247286-nexstarminus-1_8-record-revenues-still-miss-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nexstar -1.8% as record revenues still miss consensus</a></h4><ul>   <li>Nexstar Media Group (NASDAQ:<a href='https://seekingalpha.com/symbol/NXST' title='Nexstar Media Group, Inc.'>NXST</a>) is heading into the close <font color='red'>down 1.8%</font> after <a href=\"https://seekingalpha.com/news/3247036-nexstar-media-eps-0_67\" target=\"_blank\">Q4 earnings missed</a> though revenue and operating income hit records.</li>    <li>Revenues rose 22.8% to $309.9M; operating income was $92.5M, and EBITDA of $134.8M beat an expected $128.8M.</li>    <li>Revenue breakout: Local, $101.9M (down 0.8%); National, $36.2M (down 12.5%); Political revenue, $60M (up 661%); Retransmission fees, $100.3M (up 22.8%); Digital, $25.75M (down 12.1%); Trade and Barter, $10.9M (down 11.7%).</li>    <li>With its acquisition of Media General complete, Nexstar is expecting average annual free cash flow in the 2017-2018 cycle of about $565M, says CEO Perry Sook. That's about $12/share, based on estimates of about $81M in year-one synergies.</li>    <li><a href=\"https://seekingalpha.com/pr/16755385-nexstar-media-fourth-quarter-net-revenue-rises-22_8-percent-record-309_9-million\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247286\" data-linked=\"Nexstar -1.8% as record revenues still miss consensus\" data-tweet=\"$NXST - Nexstar -1.8% as record revenues still miss consensus https://seekingalpha.com/news/3247286-nexstarminus-1_8-record-revenues-still-miss-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3247286-nexstarminus-1_8-record-revenues-still-miss-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247300\" data-ts=\"1488315569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247300-u-s-set-to-export-first-lng-on-canadas-behalf-from-chenieres-sabine-pass\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. set to export first LNG on Canada&#39;s behalf from Cheniere&#39;s Sabine Pass</a></h4><ul>     <li>Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='red'>-2.1%</font>) is lower despite reported its <a href=\"http://fuelfix.com/blog/2017/02/28/cheniere-energy-turns-first-quarterly-profit/\" target=\"_blank\">first unadjusted quarterly profit</a> now that revenue is streaming in regularly (<a href=\"https://seekingalpha.com/news/3247086-cheniere-energy-misses-0_04-revenue-line\" target=\"_blank\">Q4 results</a>).</li>     <li>LNG says it it is <a href=\"https://www.bloomberg.com/news/articles/2017-02-28/america-looks-set-to-export-first-lng-on-canada-s-behalf\" target=\"_blank\">set to receive Canadian supplies</a> from the Montney shale play, part of the company&rsquo;s strategy to tap into different supply basins after&nbsp;opening up its landmark gas export terminal at Sabine Pass in Louisiana a year ago.</li>     <li>LNG is thus achieving what opponents of the Keystone XL oil pipeline wanted to prevent: bringing resources from Canada that could end up being exported from the U.S.</li>     <li>&ldquo;This is a great potential outlet\" for Cheniere, Pira Energy Group's Madeline Jowdy tells Bloomberg, since strident opposition has made British Columbia's various proposed export projects look like they are going to be a long time coming, if ever.</li><li>LNG has two of its&nbsp;natural gas liquefaction facilities online and producing gas for export at Sabine Pass, with a third train expected to come online in March, a fourth scheduled  for the fall, a fifth seen finished by 2019, and a  sixth without a timetable so far.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247300\" data-linked=\"U.S. set to export first LNG on Canada&#39;s behalf from Cheniere&#39;s Sabine Pass\" data-tweet=\"$LNG - U.S. set to export first LNG on Canada&#39;s behalf from Cheniere&#39;s Sabine Pass https://seekingalpha.com/news/3247300-u-s-set-to-export-first-lng-on-canadas-behalf-from-chenieres-sabine-pass?source=tweet\" data-url=\"https://seekingalpha.com/news/3247300-u-s-set-to-export-first-lng-on-canadas-behalf-from-chenieres-sabine-pass\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247285\" data-ts=\"1488315451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247285-trading-in-lexicon-pharma-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Lexicon Pharma halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Lexicon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color='red'>-2.5%</font>) pending news. Today is the FDA's action date for its marketing application for telotristat etiprate for carcinoid syndrome.</li><li>The original action date &#40;PDUFA&#41; was November 30, 2016 but was extended after the company submitted additional clinical data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247285\" data-linked=\"Trading in Lexicon Pharma halted pending news\" data-tweet=\"$LXRX - Trading in Lexicon Pharma halted pending news https://seekingalpha.com/news/3247285-trading-in-lexicon-pharma-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3247285-trading-in-lexicon-pharma-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247284\" data-ts=\"1488315079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247284-valeants-ugly-q4-and-soft-guidance-belies-papas-turnaround-story-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant&#39;s ugly Q4 and soft guidance belies Papa&#39;s turnaround story; shares down 14%</a></h4><ul><li>Valeant Pharmaceuticals' (VRX <font color='red'>-13.8%</font>) almost 30% rally since late January seems like a distant memory after it posted Q4 and full-year results earlier today that showed declines across its businesses. The company did itself no favors by stating that it would provide guidance on cash flow ops and net income, but didn't provide any. It added that it will no longer provide an outlook for non-GAAP net income or non-GAAP EPS.</li><li>Unsurprisingly, analysts lack confidence that the company can, indeed, reverse its fortunes.</li><li>Wells Fargo's David Maris: Investors should scrutinize the company's claims of a turnaround very carefully since \"all franchises appear to be stagnating or in decline.\" Estimates interest coverage ratio of 2.07x, \"very close\" to its 2.0x covenant. Rating: Hold.</li><li>Mizuho's Irina Koffler: Management's expectations of 2 - 5% growth in Rx and 5 - 7% growth for B&amp;L in 2017 are \"unrealistic.\" Rating: Underperform.</li><li>RBC's Douglas Miehm: Non-GAAP EBITDA forecast of $3.55B - 3.70B below his target of $3.8B and below consensus of $3.9B. Guidance likely conservative, however.</li><li>Source: Bloomberg</li><li>According to a&nbsp;<a href=\"http://blogs.barrons.com/incomeinvesting/2017/02/28/valeants-leverage-could-reach-8x-or-worse-says-gimme-credit/?mod=BOL_hp_blog_ii\" target=\"_blank\">Barron's article</a>, an analyst at independent corporate bond research firm Gimme Credit says the company only paid down $1.2B in debt last year so its leverage is tracking to mid-high 7x this year depending on how much debt can be paid down via asset sales. The company's April 2026 notes are currently yielding 9.4%, reflecting the expected increased risk.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247284\" data-linked=\"Valeant&#39;s ugly Q4 and soft guidance belies Papa&#39;s turnaround story; shares down 14%\" data-tweet=\"$BHC - Valeant&#39;s ugly Q4 and soft guidance belies Papa&#39;s turnaround story; shares down 14% https://seekingalpha.com/news/3247284-valeants-ugly-q4-and-soft-guidance-belies-papas-turnaround-story-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3247284-valeants-ugly-q4-and-soft-guidance-belies-papas-turnaround-story-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>274&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247278\" data-ts=\"1488314505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORBC\" target=\"_blank\">ORBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247278-orbcomm-rises-4_7-guides-to-service-sales-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orbcomm rises 4.7% as it guides to service sales growth</a></h4><ul>   <li>Orbcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/ORBC' title='ORBCOMM Inc.'>ORBC</a>) has <font color='green'>gained 4.7%</font> after posting <a href=\"https://seekingalpha.com/news/3247033-orbcomm-misses-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a> where revenues missed but the company guided on its <a href=\"https://seekingalpha.com/article/4050566-orbcomms-orbc-ceo-marc-eisenberg-q4-2016-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a> to service revenues growing 5-8% in the coming year.</li>    <li>EPS went from break-even last year to a $0.05 loss, and ex-items went from a year-ago $0.01 gain to a $0.04 loss. But EBITDA grew to $12.5M, which beat an expected $12.3M.</li>    <li>For the full year, service revenues were up 13% to a record $112.9M, and EBITDA rose 12% to $47.3M.</li>    <li>Revenue breakout: Service revenues, $29.4M (up 8.4%); Product sales, $17.4M (down 2.5%).</li>    <li>In a new approach to guidance after difficulty timing sales and installations, for the full year Orbcomm is forecasting service revenues of $118M-$122M (5-8% growth) and product sales from $80M-$110M. Consensus expectations for total revenue sit at $209.8M.</li>    <li>It sees adjusted EBITDA margins of 25-27% of total revenues, depending on its eventual hardware/services mix.</li>    <li><a href=\"https://seekingalpha.com/pr/16755337-orbcomm-announces-fourth-quarter-full-year-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247278\" data-linked=\"Orbcomm rises 4.7% as it guides to service sales growth\" data-tweet=\"$ORBC - Orbcomm rises 4.7% as it guides to service sales growth https://seekingalpha.com/news/3247278-orbcomm-rises-4_7-guides-to-service-sales-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3247278-orbcomm-rises-4_7-guides-to-service-sales-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247276\" data-ts=\"1488314454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPO\" target=\"_blank\">FPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247276-rough-session-for-office-reits-led-first-potomac\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for office REITs led by First Potomac</a></h4><ul><li>Evercore earlier said property comps at First Potomac (<a href='https://seekingalpha.com/symbol/FPO' title='First Potomac Realty Trust'>FPO</a> <font color='red'>-4.4%</font>) are going to become more difficult this year thanks to higher occupancy rates. With planned asset sales nearly complete, the company needs to be on the lookout for acquisitions to help growth, or perhaps use equity capital to cut leverage.</li><li>Government Properties (<a href='https://seekingalpha.com/symbol/GOV-OLD' title='Government Properties Income Trust'>GOV-OLD</a> <font color='red'>-1.9%</font>), Equity Commonwealth (<a href='https://seekingalpha.com/symbol/EQC' title='Equity Commonwealth'>EQC</a> <font color='red'>-2.3%</font>), Washington Real Estate (<a href='https://seekingalpha.com/symbol/WRE' title='Washington Real Estate Investment'>WRE</a> <font color='red'>-1.7%</font>), City Office (<a href='https://seekingalpha.com/symbol/CIO' title='City Office REIT, Inc.'>CIO</a> <font color='red'>-1.1%</font>)</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3247276\" data-linked=\"Rough session for office REITs led by First Potomac\" data-tweet=\"$FPO $FPO $GOV-OLD - Rough session for office REITs led by First Potomac https://seekingalpha.com/news/3247276-rough-session-for-office-reits-led-first-potomac?source=tweet\" data-url=\"https://seekingalpha.com/news/3247276-rough-session-for-office-reits-led-first-potomac\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247270\" data-ts=\"1488312517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247270-gamestopminus-9-after-new-xbox-subscription-plan-unveiled\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop -9% after new Xbox subscription plan unveiled</a></h4><ul><li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) is&nbsp;<font color='red'>down 9.28% </font>on heavy volume after Microsoft announces a new $9.99 subscription for the Xbox.</li><li>The Xbox Game Pass will debut this spring.</li><li>Baird doubles down on it Outperform rating on GME, recommending that investors buy into today's weakness.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247270\" data-linked=\"GameStop -9% after new Xbox subscription plan unveiled\" data-tweet=\"$GME - GameStop -9% after new Xbox subscription plan unveiled https://seekingalpha.com/news/3247270-gamestopminus-9-after-new-xbox-subscription-plan-unveiled?source=tweet\" data-url=\"https://seekingalpha.com/news/3247270-gamestopminus-9-after-new-xbox-subscription-plan-unveiled\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247267\" data-ts=\"1488312034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247267-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='green'>+11%</font>. LFGR <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PDVW' title='pdvWireless, Inc.'>PDVW</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247267\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$WUBA $TTD $IPDN - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3247267-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3247267-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247266\" data-ts=\"1488311893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247266-first-solar-rated-sell-axiom-solar-bear-johnson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar rated a Sell by Axiom solar bear Johnson</a></h4><ul>     <li>First Solar (<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='red'>-4.4%</font>) is initiated with a <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9107951/wall-streets-biggest-solar-power-bear-thinks-first-solar\" target=\"_blank\">Sell rating</a> and $21 price target at Axiom Capital, which says the six large legacy projects the company has used to bolster earnings in recent years are now gone.</li>     <li>The projects allowed FSLR to &ldquo;defer high-quality revenue and margins to future periods, providing years of EPS buffer during earnings down-cycles,&rdquo; but now those projects are gone, Axiom's Gordon Johnson writes, \"so now the company has to compete on the merits of its technology, and, quite frankly, I don&rsquo;t think they can compete against the Chinese.\"</li>     <li>Johnson also criticizes FSLR&rsquo;s 8Point3 Energy Partners (<a href='https://seekingalpha.com/symbol/CAFD' title='8point3 Energy Partners LP'>CAFD</a> <font color='red'>-0.4%</font>) yield company, which uses non-amortizing revolver debt \"when they should be using amortizing term debt like every other yieldco.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3247266\" data-linked=\"First Solar rated a Sell by Axiom solar bear Johnson\" data-tweet=\"$FSLR $FSLR $CAFD - First Solar rated a Sell by Axiom solar bear Johnson https://seekingalpha.com/news/3247266-first-solar-rated-sell-axiom-solar-bear-johnson?source=tweet\" data-url=\"https://seekingalpha.com/news/3247266-first-solar-rated-sell-axiom-solar-bear-johnson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247261\" data-ts=\"1488311023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247261-seadrill-stillminus-12-after-chapter-11-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill still -12% after Chapter 11 warning</a></h4><ul>     <li>Seadrill (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-12.5%</font>) maintains heavy losses after <a href=\"https://seekingalpha.com/news/3247075-seadrill-minus-12-percent-warns-possible-chapter-11-bankruptcy\" target=\"_blank\">warning</a> that it could be forced into bankruptcy protection in two months, as well as risks of &rdquo;substantial dilution&rdquo; of bonds converting into equity.</li><li>A lending facility linked to the West Eminence, one of the company&rsquo;s rigs, matures on April 30, the same date as a &ldquo;milestone&rdquo; under amendments to the company&rsquo;s bank facilities agreed last year.</li><li>Canaccord Genuity notes that Q4 results showed a strong operational performance but little chance of any significant accretion of value from customer contracts in the next 12-18 months; the firm sees a real possibility that SDRL might need to seek protection from its creditors in an insolvency after the April 30 deadline.</li><li>DNB&nbsp;Marekts considers a bond conversion to equity a positive from a company perspective, but sees a risk of shareholders being marginalized in the restructuring.</li><li>Simmons analysts believes a pending bankruptcy at SDRL has looked inescapable for some time; all three firms rate the stock a Sell.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247261\" data-linked=\"Seadrill still -12% after Chapter 11 warning\" data-tweet=\"$SDRL - Seadrill still -12% after Chapter 11 warning https://seekingalpha.com/news/3247261-seadrill-stillminus-12-after-chapter-11-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3247261-seadrill-stillminus-12-after-chapter-11-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247259\" data-ts=\"1488309824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247259-afternoon-bounce-for-oil-on-white-house-opec-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Afternoon bounce for oil on White House, OPEC news</a></h4><ul><li><a href=\"http://www.zerohedge.com/news/2017-02-28/oil-spikes-opecwhite-house-headlines\" target=\"_blank\">First up was</a> a White House denial of rumors it's putting together an executive order to rescind ethanol mandates.</li><li>Next was a Reuters survey showing OPEC continues to deliver on promised supply cuts, with members now having achieved 1.098M b/d of reductions vs. 1.164M pledged, or 94% compliance.</li><li>Oil has added about $0.60 since the stories hit, but remains lower on the session<font color='red'> by 0.4%</font>&nbsp;at $53.83 per barrel.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a><font color='red'> -0.6%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247259\" data-linked=\"Afternoon bounce for oil on White House, OPEC news\" data-tweet=\"$USO $OIL $UCO - Afternoon bounce for oil on White House, OPEC news https://seekingalpha.com/news/3247259-afternoon-bounce-for-oil-on-white-house-opec-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3247259-afternoon-bounce-for-oil-on-white-house-opec-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247255\" data-ts=\"1488308390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247255-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/DK' title='Delek US Holdings, Inc.'>DK</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AREX' title='Approach Resources Inc.'>AREX</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247255\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$LXU $ALB $ICD - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3247255-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3247255-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247253\" data-ts=\"1488307759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRTEA\" target=\"_blank\">QRTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247253-liberty-interactiveminus-7_8-u-s-qvc-drags-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Interactive -7.8% as U.S. QVC drags sales</a></h4><ul>   <li>Liberty Interactive (QVCA) is <font color='red'>off 7.8%</font> now after its <a href=\"https://seekingalpha.com/news/3247117-liberty-interactive-misses-revenue\" target=\"_blank\">Q4 revenues</a> missed expectations as QVC Group sales fell 3%.</li>    <li>EBITDA at that group dipped 2% to $610M, and its net income fell 15%. Gross margins dipped at QVC U.S. and international as well, while they increased by nearly 2 percentage points at Zulily.</li>    <li>Revenue by segment: QVC US, $1.95B (down 7%); QVC International, $711M (flat); Zulily, $467M (up 10%).</li>    <li>&ldquo;Internationally, QVC continues to perform well, while domestically we are focusing on strengthening a few merchandise categories that have been weak,&rdquo; says CEO Greg Maffei.</li>    <li><a href=\"https://seekingalpha.com/pr/16755695-liberty-interactive-corporation-reports-fourth-quarter-year-end-2016-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247253\" data-linked=\"Liberty Interactive -7.8% as U.S. QVC drags sales\" data-tweet=\"$QRTEA - Liberty Interactive -7.8% as U.S. QVC drags sales https://seekingalpha.com/news/3247253-liberty-interactiveminus-7_8-u-s-qvc-drags-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3247253-liberty-interactiveminus-7_8-u-s-qvc-drags-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247240\" data-ts=\"1488305230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247240-cowens-cacciatore-doesnt-see-upside-in-endo-cuts-price-target-to-16-shares-up-5-after-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen&#39;s Cacciatore doesn&#39;t see upside in Endo, cuts price target to $16; shares up 5% after Q4 beat</a></h4><ul><li>Cowen and Company's Ken Cacciatore says Endo International's (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+5%</font>) continued exposure to mesh liability payments and high leverage make it a value trap since its operations are not generating enough cash to pay down the debt. He has reduced his price target to $16 (14% upside) from $30.</li><li>Mr. Cacciatore adds that Shire (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-1.4%</font>) and Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-0.4%</font>) are more attractive plays. He rates both Outperform with price targets of $181 and $245, respectively.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3247240\" data-linked=\"Cowen&#39;s Cacciatore doesn&#39;t see upside in Endo, cuts price target to $16; shares up 5% after Q4 beat\" data-tweet=\"$ENDP $ENDP $SHPG - Cowen&#39;s Cacciatore doesn&#39;t see upside in Endo, cuts price target to $16; shares up 5% after Q4 beat https://seekingalpha.com/news/3247240-cowens-cacciatore-doesnt-see-upside-in-endo-cuts-price-target-to-16-shares-up-5-after-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3247240-cowens-cacciatore-doesnt-see-upside-in-endo-cuts-price-target-to-16-shares-up-5-after-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247241\" data-ts=\"1488304822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247241-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SBY' title='Silver Bay Realty Trust Corp.'>SBY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IPCC' title='Infinity Property and Casualty Corporation'>IPCC</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NNI' title='Nelnet, Inc.'>NNI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AIII' title='ACRE Realty Investors Inc.'>AIII</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SSBI' title='Summit State Bank'>SSBI</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247241\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$SBY $CARV $IPCC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3247241-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3247241-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247243\" data-ts=\"1488304613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALB\" target=\"_blank\">ALB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247243-albemarleplus-10-after-q4-beat-guides-2017-revenues-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albemarle +10% after Q4 beat; guides 2017 revenues above consensus</a></h4><ul><li>Albemarle (<a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a> <font color='green'>+9.7%</font>) surges to 52-week highs after posting better than expected <a href=\"https://seekingalpha.com/news/3246927-albemarle-beats-0_05-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, and ending 2016 with ~$2.3B in cash, a more than 10x Y/Y increase.</li><li>ALB issues FY 2017 guidance, seeing EPS of $4.00-$4.25 vs. $4.10 analyst consensus estimate on revenues of $2.80B-$2.95B vs. $2.78B consensus.</li><li>For Q4, sales from the lithium and advanced materials unit jumped 30% Y/Y to $278M, bromine specialties sales gained 13% to $194.5M, and revenues from the refining solutions unit fell 4% to $193M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247243\" data-linked=\"Albemarle +10% after Q4 beat; guides 2017 revenues above consensus\" data-tweet=\"$ALB - Albemarle +10% after Q4 beat; guides 2017 revenues above consensus https://seekingalpha.com/news/3247243-albemarleplus-10-after-q4-beat-guides-2017-revenues-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3247243-albemarleplus-10-after-q4-beat-guides-2017-revenues-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247236\" data-ts=\"1488304314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247236-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BASI' title='Bioanalytical Systems, Inc.'>BASI</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SBY' title='Silver Bay Realty Trust Corp.'>SBY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/GRAM-OLD' title='Graa y Montero'>GRAM-OLD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a> <font color='green'>+13%</font>. ETRM <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/FRGI' title='Fiesta Restaurant Group, Inc.'>FRGI</a> <font color='red'>-24%</font>. INCR <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/DFIN' title='Donnelley Financial Solutions, Inc.'>DFIN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/KONA' title='Kona Grill, Inc.'>KONA</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ICFI' title='ICF International, Inc.'>ICFI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NNI' title='Nelnet, Inc.'>NNI</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247236\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$BASI $LXU $NTRI - Midday Gainers / Losers https://seekingalpha.com/news/3247236-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3247236-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247232\" data-ts=\"1488303710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIU\" target=\"_blank\">ACIU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247232-genentech-readies-second-late-stage-study-of-crenezumab-in-alzheimers-licensor-ac-immune-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genentech readies second late-stage study of crenezumab in Alzheimer&#39;s; licensor AC Immune up 3%</a></h4><ul><li>Thinly traded AC Immune SA (<a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a> <font color='green'>+2.6%</font>) perks up on modestly higher volume in response to Genentech's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) <a href=\"https://seekingalpha.com/pr/16755091-ac-immune-partner-genentech-start-second-phase-3-clinical-trial-alzheimers-therapy-crenezumab\" target=\"_blank\">decision </a>to start a second Phase 3 study called CREAD2 assessing crenezumab in patients with mild Alzheimer's disease.</li><li>Top-line data from the first Phase 3, CREAD1, are expected in 2020.</li><li>Crenezumab is a fully humanized IgG4 monoclonal antibody that binds to all forms of misfolded Abeta proteins, especially Abeta oligomers, to prevent and break up Abeta aggregation and promote Abeta disaggregation. Tau and beta amyloid (Abeta) are associated with neurodegeneration. Tangles and aggregations in the brain characterize Alzheimer's disease.</li><li>The company out-licensed crenezumab to Genentech in 2006.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247232\" data-linked=\"Genentech readies second late-stage study of crenezumab in Alzheimer&#39;s; licensor AC Immune up 3%\" data-tweet=\"$ACIU $ACIU $RHHBY - Genentech readies second late-stage study of crenezumab in Alzheimer&#39;s; licensor AC Immune up 3% https://seekingalpha.com/news/3247232-genentech-readies-second-late-stage-study-of-crenezumab-in-alzheimers-licensor-ac-immune-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3247232-genentech-readies-second-late-stage-study-of-crenezumab-in-alzheimers-licensor-ac-immune-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247229\" data-ts=\"1488303053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247229-bloomberg-trump-considers-biofuel-plan-brought-icahn-ethanol-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Trump considers biofuel plan brought by Icahn, ethanol group</a></h4><ul>     <li>Refining stocks are mostly higher after Bloomberg reports that Pres. Trump is considering a plan submitted by Carl Icahn and the Renewable Fuels Association that would <a href=\"https://www.bloomberg.com/news/articles/2017-02-28/trump-said-to-consider-biofuel-plan-between-icahn-ethanol-group\" target=\"_blank\">shift the point of obligation for RINs away from refiners</a> and toward fuel blenders.</li>     <li>Oil refiners, including Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='green'>+2.2%</font>) and CVR Energy (<a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color='green'>+3.2%</font>), have l<a href=\"http://www.reuters.com/article/us-usa-trump-renewables-idUSKBN1671PD\" target=\"_blank\">ong sought such a change</a>, saying the structure of the U.S. biofuels program hits them with burdensome costs.</li>     <li>Prices for biofuel credits plunged 35% on the news while futures contracts for corn, the raw material used to manufacture ethanol, surged.</li>     <li>The biofuels trade group had just this month filed comments with  the EPA opposing the move, but now it has agreed to back the change in  return for a pledge for a waiver allowing gasoline blends containing 15% ethanol to be sold year-round in U.S. markets.</li><li>Growth Energy, a separate group of biofuel supporters including Green Plains (<a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='green'>+5%</font>), blasts the reported deal, saying \"this is no deal for anyone but Carl Icahn.\"</li><li>Also: <a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corp.'>HFC</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='green'>+4.7%</font>, <a href='https://seekingalpha.com/symbol/DK' title='Delek US Holdings, Inc.'>DK</a> <font color='green'>+7.4%</font>, <a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corp.'>HFC</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/ALJ' title='Alon USA Energy, Inc.'>ALJ</a> <font color='green'>+6.5%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='red'>-0.7%</font>, <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='red'>-1.2%</font>, TSO <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/WNR' title='Western Refining, Inc.'>WNR</a> <font color='red'>-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247229\" data-linked=\"Bloomberg: Trump considers biofuel plan brought by Icahn, ethanol group\" data-tweet=\"$VLO $VLO $CVI - Bloomberg: Trump considers biofuel plan brought by Icahn, ethanol group https://seekingalpha.com/news/3247229-bloomberg-trump-considers-biofuel-plan-brought-icahn-ethanol-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3247229-bloomberg-trump-considers-biofuel-plan-brought-icahn-ethanol-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247228\" data-ts=\"1488302960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNS\" target=\"_blank\">BNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247228-scotiabankminus-2-after-inline-quarter-dividend-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scotiabank -2% after inline quarter, dividend hike</a></h4><ul><li>FQ1 EPS of C$1.57 met analyst expectations, led by a 28% increase in profit in global banking and markets.</li><li>Net interest income rose 3.5% Y/Y, and noninterest income gained 13%. ROE of 14.3% was 50 basis points from a year earlier.</li><li>Provisions edged up to $553M from $539M.</li><li>The dividend is hiked 3% to C$0.76 per share.</li><li>Investors are nevertheless taking a profits after the bank's big run higher (up&nbsp;<font color='green'>nearly 50%&nbsp;</font>Y/Y). <a href='https://seekingalpha.com/symbol/BNS' title='The Bank of Nova Scotia'>BNS</a><font color='red'> -2%</font>&nbsp;today.</li><li><a href=\"https://seekingalpha.com/article/4050506-bank-nova-scotias-bns-ceo-brian-porter-q1-2017-results-earnings-call-transcript\" target=\"_blank\">Conference call transcript</a></li><li><a href=\"https://seekingalpha.com/article/4050330-bank-nova-scotia-2017-q1-results-earnings-call-slides\" target=\"_blank\">Conference call slide presentation</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3247017-bank-nova-scotia-declares-cad-0_76-dividend\" target=\"_blank\">Bank of Nova Scotia declares CAD 0.76 dividend</a> (Feb. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246998-bank-nova-scotia-eps-line\" target=\"_blank\">Bank of Nova Scotia EPS in-line</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247228\" data-linked=\"Scotiabank -2% after inline quarter, dividend hike\" data-tweet=\"$BNS - Scotiabank -2% after inline quarter, dividend hike https://seekingalpha.com/news/3247228-scotiabankminus-2-after-inline-quarter-dividend-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3247228-scotiabankminus-2-after-inline-quarter-dividend-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247224\" data-ts=\"1488301628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247224-pandora-dips-4_2-on-liberty-chiefs-valuation-commentary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora dips 4.2% on Liberty chief&#39;s valuation commentary</a></h4><ul>     <li>Pandora (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) -- this year, moving as much on comments from Liberty Media (NASDAQ:<a href='https://seekingalpha.com/symbol/FWONA' title='Liberty Media Corp'>FWONA</a>) chief Greg Maffei as on fundamentals -- took a sudden tumble and is now <font color='red'>down 4.2%</font> as Maffei says on his earnings call that Pandora's valuation doesn't quite make sense but it would be \"interesting\" at the right price.</li>     <li>There's \"no wedge\" on Pandora between Liberty and Sirius XM (<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a> <font color='red'>-1.3%</font>), of which Liberty owns 67.1%.</li>   <li>Earlier this month, Pandora rose on an FBN Securities analyst's thoughts about whether <a href=\"https://seekingalpha.com/news/3244513-pandora-plus-2_8-percent-fbn-sees-sirius-xm-buyout-clues-buffett-13f\" target=\"_blank\">Warren Buffet's 13F gave clues</a> to a Sirius/Pandora combination. Last year, the stock moved on reports that Liberty had <a href=\"https://seekingalpha.com/news/3194850-wsj-liberty-floated-15-share-offer-pandora-combine-sirius-xm\" target=\"_blank\">floated a $15/share offer</a> to merge the two.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247224\" data-linked=\"Pandora dips 4.2% on Liberty chief&#39;s valuation commentary\" data-tweet=\"$P $P $FWONA - Pandora dips 4.2% on Liberty chief&#39;s valuation commentary https://seekingalpha.com/news/3247224-pandora-dips-4_2-on-liberty-chiefs-valuation-commentary?source=tweet\" data-url=\"https://seekingalpha.com/news/3247224-pandora-dips-4_2-on-liberty-chiefs-valuation-commentary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247218\" data-ts=\"1488301213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247218-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247218\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$ESND $LBY $LFVN - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3247218-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3247218-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247214\" data-ts=\"1488300813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYDY\" target=\"_blank\">CYDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247214-cytodyn-executes-4_25m-capital-raise-via-direct-equity-offering-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytoDyn executes $4.25M capital raise via direct equity offering; shares down 4%</a></h4><ul><li>Thinly traded nano cap CytoDyn (<a href='https://seekingalpha.com/symbol/CYDY' title='CytoDyn Inc.'>OTCQB:CYDY</a> <font color='red'>-3.5%</font>) eases on modest volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1175680/000119312517060251/d335121d8k.htm\" target=\"_blank\">agreement </a>to sell 5,670,661 shares of common stock at $0.75 per share to certain investors in a registered direct offering. Investors will also receive five-year warrants to purchase 2,835,323 common shares at $1.00.</li><li>Net proceeds should be ~$3.8M. Closing date is today.</li><li>Yesterday's close was $0.72.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247214\" data-linked=\"CytoDyn executes $4.25M capital raise via direct equity offering; shares down 4%\" data-tweet=\"$CYDY - CytoDyn executes $4.25M capital raise via direct equity offering; shares down 4% https://seekingalpha.com/news/3247214-cytodyn-executes-4_25m-capital-raise-via-direct-equity-offering-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3247214-cytodyn-executes-4_25m-capital-raise-via-direct-equity-offering-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247211\" data-ts=\"1488300382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247211-alliqua-bio-axes-soluble-systems-buy-shares-ease-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliqua Bio axes Soluble Systems buy; shares ease 6%</a></h4><ul><li>Thinly traded nano cap Alliqua BioMedical (<a href='https://seekingalpha.com/symbol/ALQA' title='Alliqua BioMedical, Inc.'>ALQA</a> <font color='red'>-5.2%</font>) <a href=\"https://seekingalpha.com/pr/16755419-alliqua-biomedical-inc-announces-termination-agreement-acquire-soluble-systems-llc\" target=\"_blank\">terminates </a>its agreement to acquire Soluable Systems, LLC due to its inability to raise the necessary capital to get the deal done.</li><li>CEO David Johnson says, &ldquo;While the announced merger agreement with Soluble Systems represented an opportunity to combine two strong regenerative technology companies, we were unable to secure the requisite financing to meet the closing conditions of the merger agreement. While we are disappointed that the public equity market conditions were not supportive of this merger, we continue to believe the strategic rationale was compelling.&rdquo;</li><li>The potential merger was announced in October 2016.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247211\" data-linked=\"Alliqua Bio axes Soluble Systems buy; shares ease 6%\" data-tweet=\"$ALQA $ADYX - Alliqua Bio axes Soluble Systems buy; shares ease 6% https://seekingalpha.com/news/3247211-alliqua-bio-axes-soluble-systems-buy-shares-ease-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3247211-alliqua-bio-axes-soluble-systems-buy-shares-ease-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247212\" data-ts=\"1488300315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247212-intelsatminus-7_3-merger-news-overshadows-solid-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat -7.3% as merger news overshadows solid earnings</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) is <font color='red'>7.3% lower</font> this morning after posting <a href=\"https://seekingalpha.com/news/3247045-intelsat-eps-5_56\" target=\"_blank\">Q4 earnings</a> that were overshadowed by <a href=\"https://seekingalpha.com/news/3247052-intelsat-oneweb-combine\" target=\"_blank\">confirmation that it will merge</a> with OneWeb at SoftBank's behest.</li>    <li>SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) will invest $1.7B in new common and preferred shares of the combined company, which it will get at $5/share. (Intelsat alone closed at $5.87 yesterday, up from $4.69 the day before, after it spiked 25% on <a href=\"https://seekingalpha.com/news/3246854-intelsat-plus-25-percent-reports-softbank-wants-merge-oneweb\" target=\"_blank\">word the deal was imminent</a>).</li>    <li>In earnings, Intelsat beat expectations on top and bottom lines, with revenue that topped consensus despite dropping 3.6%, and net income/share of $5.56 ($662.8M) after the company took a gain on early extinguishment of debt of $679.1M (vs. a year-ago gain of $7.1M).</li>    <li>Revenue by customer set: Network Services, $221.95M (40% of total); Media, $228.35M (42% of total); Government, $93.2M (17% of total); Other, $7.2M (1%).</li>    <li>For 2017, it's forecasting revenues of $2.18B-$2.225B (above consensus for $2.158B), expecting 3-5% gains in Media, flat to -3% growth in network services and -7% to -9% in government.</li>    <li>It's also expecting EBITDA of $1.655B-$1.7B for the year, above consensus for $1.62B.</li>    <li><a href=\"https://seekingalpha.com/pr/16755332-intelsat-announces-fourth-quarter-full-year-2016-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247212\" data-linked=\"Intelsat -7.3% as merger news overshadows solid earnings\" data-tweet=\"$I $I $SFTBY - Intelsat -7.3% as merger news overshadows solid earnings https://seekingalpha.com/news/3247212-intelsatminus-7_3-merger-news-overshadows-solid-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3247212-intelsatminus-7_3-merger-news-overshadows-solid-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247207\" data-ts=\"1488299837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247207-analysts-weigh-in-on-perrigo-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts weigh in on Perrigo; shares down 11%</a></h4><ul><li>Sell-side analysts update their views on Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='red'>-11.2%</font>) after yesterday's announcements (Q4 earnings/soft guidance, sale of Tysabri royalties, resignation of CFO).</li><li>Raymond James' Elliot Wilbur: The bull case supported by a revaluation is \"losing credibility\" in light of eroding fundamentals. Price erosion assumption in generics modestly worse (9-11% versus 9-10%) than expected. Tysabri sale will help trim $5.9B debt load, but CFO exit and delay in year-end actuals \"add further agitation.\" Rates Market Perform.</li><li>Jefferies' David Steinberg: Guidance came in below the \"very significant\" cuts announced four weeks ago. Company could possible divest its generics business. Rates Hold with a $71 (5% downside risk) price target.</li><li>Guggenheim's Louise Chen: Earning potential underappreciated, many growth drivers not fully reflected in current valuation. Rx to OTC switches could drive upside to expectations. Lowered 2017 EPS to $4.12 from $6.90 but reiterates Buy rating and $125 (67% upside) price target.</li><li>BTIG's Timothy Chiang: Company should keep Rx Pharma segment since it is the most profitable. 2017 EPS target of $4.75 - 4.95. Rates Neutral.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3247207\" data-linked=\"Analysts weigh in on Perrigo; shares down 11%\" data-tweet=\"$PRGO - Analysts weigh in on Perrigo; shares down 11% https://seekingalpha.com/news/3247207-analysts-weigh-in-on-perrigo-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3247207-analysts-weigh-in-on-perrigo-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247206\" data-ts=\"1488298967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247206-online-brokers-defended-suntrust-amtdminus-10-etfcminus-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Online brokers defended at SunTrust; AMTD -10%, ETFC -7%</a></h4><ul><li>The impact from the whopping Fidelity commission cut should be less than what the headlines might suggest, says analyst Doug Mewhirter, reiterating Buy ratings on Schwab (<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a> <font color='red'>-3.9%</font>), E*Trade (<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color='red'>-7.1%</font>), and Ameritrade (<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> <font color='red'>-9.8%</font>).</li><li>Don't forget to factor in high switching costs and the fact that high volume traders already get a big discount on commissions.</li><li>Trading revenue is already playing less of a role at the brokers. The game going forward is asset-based business.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247151-brokers-tumble-fee-war-escalates\" target=\"_blank\">Brokers tumble as fee war escalates</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247206\" data-linked=\"Online brokers defended at SunTrust; AMTD -10%, ETFC -7%\" data-tweet=\"$SCHW $SCHW $ETFC - Online brokers defended at SunTrust; AMTD -10%, ETFC -7% https://seekingalpha.com/news/3247206-online-brokers-defended-suntrust-amtdminus-10-etfcminus-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3247206-online-brokers-defended-suntrust-amtdminus-10-etfcminus-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247205\" data-ts=\"1488298943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURBY\" target=\"_blank\">BURBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247205-burberry-spikes-after-gbl-discloses-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Burberry spikes after GBL discloses stake</a></h4><ul> <li>GBL Energy Sarl reports it holds a 3% stake in Burberry (<a href='https://seekingalpha.com/symbol/BURBY' title='Burberry Group Plc ADR'>OTCPK:BURBY</a>).</li> <li>GBL is one of Albert Frere's companies.</li> <li>Shares of Burberry are <font color='green'>up 7.00%</font> in London.</li> <li><a href=\"http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/BRBY/13142334.html\" target=\"_blank\">London Stock Exchange filing</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3247205\" data-linked=\"Burberry spikes after GBL discloses stake\" data-tweet=\"$BURBY - Burberry spikes after GBL discloses stake https://seekingalpha.com/news/3247205-burberry-spikes-after-gbl-discloses-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3247205-burberry-spikes-after-gbl-discloses-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247201\" data-ts=\"1488298584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPE\" target=\"_blank\">CPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247201-callon-petroleumminus-5-after-higher-expected-capex-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callon Petroleum -5% after higher than expected capex view</a></h4><ul>     <li>Callon Petroleum (<a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a> <font color='red'>-5.3%</font>) drops as much as 11% to its lowest since August&nbsp; after posting a <a href=\"https://seekingalpha.com/news/3246909-callon-petroleum-misses-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a> miss, poised for its first decline in five trading days after quarterly results.</li><li>Iberia Capital says CPE's updated 2017  capex forecast of $325M-$350M is higher than expected, although it lays the necessary groundwork for the company  to execute on its development plan in the Midland and Delaware basins.</li><li>Capital One says Q4 was  mixed though \"negative on balance,\" but the Q4 production miss \"looks  transitory\" while the Street was already at the high end of the improved  forecast.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247201\" data-linked=\"Callon Petroleum -5% after higher than expected capex view\" data-tweet=\"$CPE - Callon Petroleum -5% after higher than expected capex view https://seekingalpha.com/news/3247201-callon-petroleumminus-5-after-higher-expected-capex-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3247201-callon-petroleumminus-5-after-higher-expected-capex-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247199\" data-ts=\"1488298389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAKK\" target=\"_blank\">JAKK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247199-target-suppliers-under-pressure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target suppliers under pressure</a></h4><ul> <li>It's a tough day for a number of companies that supply Target after the retailer's huge drop in profit guidance.</li> <li>JAKKS Pacific (<a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='red'>-1.8%</font>), Emerson Radio (<a href='https://seekingalpha.com/symbol/MSN' title='Emerson Radio Corp'>MSN</a> <font color='red'>-2.3%</font>), Cherokee (<a href='https://seekingalpha.com/symbol/CHKE' title='Cherokee Inc.'>CHKE</a> <font color='red'>-3.2%</font>) and Hanesbrands (<a href='https://seekingalpha.com/symbol/HBI' title='Hanesbrands Inc.'>HBI</a> <font color='red'>-1.6%</font>) are all notably lower.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3247023-target-minus-12-percent-margins-come-pressure\" target=\"_blank\">Target -12% as margins come under pressure</a> (Feb. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247166-e-commerce-smash-grab-ravages-retail\" target=\"_blank\">E-commerce smash and grab ravages retail</a> (Feb. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247196-target-crosshairs\" target=\"_blank\">Target in the crosshairs</a> (Feb. 28)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3247199\" data-linked=\"Target suppliers under pressure\" data-tweet=\"$JAKK $JAKK $MSN - Target suppliers under pressure https://seekingalpha.com/news/3247199-target-suppliers-under-pressure?source=tweet\" data-url=\"https://seekingalpha.com/news/3247199-target-suppliers-under-pressure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247197\" data-ts=\"1488297971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBY\" target=\"_blank\">SBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247197-single-family-rental-reits-perky-after-silver-bay-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Single-family rental REITs perky after Silver Bay sale</a></h4><ul><li>Silver Bay Realty (<a href='https://seekingalpha.com/symbol/SBY' title='Silver Bay Realty Trust Corp.'>SBY</a> <font color='green'>+18.3%</font>) last night announced its sale to P-E player Tricon Capital for $21.50 per share in cash, and the stock is now trading right at that level.</li><li>Like Silver Bay, Altisource Residential (<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a> <font color='green'>+5.2%</font>) - with a market cap under $1B - is small enough to be easily swallowed. Colony Starwood (<a href='https://seekingalpha.com/symbol/SFR' title='Starwood Waypoint Homes Inc'>SFR</a> <font color='green'>+1.1%</font>), American Homes 4 Rent (<a href='https://seekingalpha.com/symbol/AMH' title='American Homes 4 Rent'>AMH</a> <font color='green'>+0.3%</font>), and recently gone-public Invitation Homes (<a href='https://seekingalpha.com/symbol/INVH' title='Invitation Homes'>INVH</a> <font color='green'>+0.5%</font>) all have market caps north of $3B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246841-silver-bay-sold-tricon-capital-20-percent-hours\" target=\"_blank\">Silver Bay sold to Tricon Capital; up 20% after hours</a> (Feb. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247197\" data-linked=\"Single-family rental REITs perky after Silver Bay sale\" data-tweet=\"$SBY $SBY $RESI - Single-family rental REITs perky after Silver Bay sale https://seekingalpha.com/news/3247197-single-family-rental-reits-perky-after-silver-bay-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3247197-single-family-rental-reits-perky-after-silver-bay-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247196\" data-ts=\"1488297753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247196-target-in-crosshairs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target in the crosshairs</a></h4><ul> <li>Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-11.8%</font>)&nbsp;CFO Catherine Smith says the company will invest $2B into the business this year and $7B over the next three years. The investments from the retailer will include backing its increased shift to digital, pricing and supporting new brands.</li> <li>The company will also increase its focus on the small-store format, with more than 100 smaller stores expected to be operating within three years. About 600 stores will be refurbished over the same three-year timeframe.</li> <li>Consumer Edge Research analyst David Schick: \"The early look at the reset includes accelerated investments in a network of physical and digital assets and lower gross margins to be competitively priced.\"</li> <li>Baird: The firm notes the company is taking the \"difficult\" steps to reset its financial plan.</li> <li>Bloomberg Intelligence: Analyst Jennifer Bartashus questions if the low pricing strategy will actually lead to traffic gains. The strategy on food is also questioned.</li> <li><a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9106256/targets-conservative-near-term-guidance-is-necessary-for\" target=\"_blank\">UBS</a> on the Q4 numbers: \"On a 2-year stack, it represents a -130 bps sequential deceleration. Its store contribution to its comp was -3.3 percent, which was partially offset by a 1.8 percent contribution from digital.\"</li><li>Retail analyst <a href=\"https://twitter.com/Retail_Guru/status/836562396097359873\" target=\"_blank\">Rahul Sharma</a>: \"$TGT caught in headlights between $WMT &amp; $AMZN. Not enough food to keep store traffic up, not enough non-food wow to compensate.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247023-target-minus-12-percent-margins-come-pressure\" target=\"_blank\">Target -12% as margins come under pressure</a> (Feb. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3247166-e-commerce-smash-grab-ravages-retail\" target=\"_blank\">E-commerce smash and grab ravages retail</a> (Feb. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3247196\" data-linked=\"Target in the crosshairs\" data-tweet=\"$TGT - Target in the crosshairs https://seekingalpha.com/news/3247196-target-in-crosshairs?source=tweet\" data-url=\"https://seekingalpha.com/news/3247196-target-in-crosshairs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247169\" data-ts=\"1488297567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247169-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/HSKA' title='Heska Corporation'>HSKA</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KND' title='Kindred Healthcare, Inc.'>KND</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247169\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$LIFE $MBOT $KITE - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3247169-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3247169-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247191\" data-ts=\"1488296356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KONA\" target=\"_blank\">KONA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247191-post-earnings-slide-for-kona-grill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for Kona Grill</a></h4><ul> <li>Kona Grill (NASDAQ:<a href='https://seekingalpha.com/symbol/KONA' title='Kona Grill, Inc.'>KONA</a>) <font color='red'>falls 16%</font> after Q4 results arrive below expectations.</li> <li>Same-store sales declined 4.1% during the quarter as the chain lost market share. Restaurant operating profit was down 17% Y/Y.</li> <li>Feltl peels back on its view on the restaurant stock, moving to a Buy rating from Strong Buy and lowering its price target to $11 from $16.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3246833-kona-grill-misses-0_07-misses-revenue\" target=\"_blank\">Kona Grill misses by $0.07, misses on revenue</a> (Feb. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247191\" data-linked=\"Post-earnings slide for Kona Grill\" data-tweet=\"$KONA - Post-earnings slide for Kona Grill https://seekingalpha.com/news/3247191-post-earnings-slide-for-kona-grill?source=tweet\" data-url=\"https://seekingalpha.com/news/3247191-post-earnings-slide-for-kona-grill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247189\" data-ts=\"1488296229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRQ\" target=\"_blank\">DRQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247189-dril-quipminus-7-following-q4-results-gloomy-2017-commentary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dril-Quip -7% following Q4 results, gloomy 2017 commentary</a></h4><ul>     <li>Dril-Quip (<a href='https://seekingalpha.com/symbol/DRQ' title='Dril-Quip, Inc.'>DRQ</a> <font color='red'>-6.8%</font>) sinks after <a href=\"https://seekingalpha.com/news/3246994-dril-quip-misses-0_07-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues come in below expectations, and the company's year-end 2016 backlog is less than half the year-end 2015 total - $318M compared to $685M.</li>     <li>DRQ cites revenue shortfalls in each of its major operating regions, as operators continued to defer spending amid difficult market conditions; results also were hurt by non-recurring items, including costs associated with the TIW acquisition and one-time inventory adjustments.</li>     <li>DRQ says 2017 will be a challenging year for the company and for the entire offshore sector, and that it has further cut employee headcount during Q1 and began pay reductions.</li><li>Citing reduced backlog and uncertainty of book-and-ship  order volumes, DRQ is not providing 2017 earnings guidance but expects Q1 to be its most challenging quarter of the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247189\" data-linked=\"Dril-Quip -7% following Q4 results, gloomy 2017 commentary\" data-tweet=\"$DRQ - Dril-Quip -7% following Q4 results, gloomy 2017 commentary https://seekingalpha.com/news/3247189-dril-quipminus-7-following-q4-results-gloomy-2017-commentary?source=tweet\" data-url=\"https://seekingalpha.com/news/3247189-dril-quipminus-7-following-q4-results-gloomy-2017-commentary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247187\" data-ts=\"1488295701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247187-xtants-interim-chief-now-permanent-shares-ahead-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xtant&#39;s interim chief now permanent; shares ahead 17%</a></h4><ul><li>Thinly traded nano cap Xtant Medical Holdings (<a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+17%</font>) perks up on more than double normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/16750022-xtant-medical-announces-appointment-carl-oconnell-permanent-ceo\" target=\"_blank\">announcement </a>that interim CEO Carl O'Connell was named permanent CEO on February 17. He served as President since October 2016 and interim CEO since January 21.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247187\" data-linked=\"Xtant&#39;s interim chief now permanent; shares ahead 17%\" data-tweet=\"$XTNT - Xtant&#39;s interim chief now permanent; shares ahead 17% https://seekingalpha.com/news/3247187-xtants-interim-chief-now-permanent-shares-ahead-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3247187-xtants-interim-chief-now-permanent-shares-ahead-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247186\" data-ts=\"1488295470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLAB\" target=\"_blank\">SLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247186-silicon-labsminus-5_8-following-disclosure-of-proposed-350m-convertible-senior-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Labs -5.8% following disclosure of proposed $350M convertible senior note offering</a></h4><ul><li>Convertible senior notes, due 2022, are to be offered via private offering to qualified institutional buyers. Purchase of up to $50M principal amount of additional notes is expected to be granted to initial purchasers through a 30-day option.</li><li>Proceeds are intended for repayment of the company's existing credit facility ($72.5M) and general corporate purposes.</li><li>Silicon Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SLAB' title='Silicon Laboratories, Inc.'>SLAB</a>) $68.20.</li><li><a href=\"https://seekingalpha.com/pr/16754708-silicon-labs-announces-proposed-private-offering-350-million-convertible-senior-notes\" target=\"_blank\">Press release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247186\" data-linked=\"Silicon Labs -5.8% following disclosure of proposed $350M convertible senior note offering\" data-tweet=\"$SLAB - Silicon Labs -5.8% following disclosure of proposed $350M convertible senior note offering https://seekingalpha.com/news/3247186-silicon-labsminus-5_8-following-disclosure-of-proposed-350m-convertible-senior-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3247186-silicon-labsminus-5_8-following-disclosure-of-proposed-350m-convertible-senior-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247182\" data-ts=\"1488295266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247182-yields-dip-despite-strong-economic-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yields dip despite strong economic news</a></h4><ul><li>The revision to 2016 Q4 GDP came in soft at just 1.9% - unchanged from the initial estimate, but missing estimates of 2.1% - but that's old news as we're just one month away from 2017 Q2.</li><li>More topical is a big gain in consumer confidence in February to 114.8 - the highest level since July 2001.</li><li>Then there's the Chicago PMI, which popped a full 7.1 points to 57.4 in February - the strongest print in more than two years. Helping was a 10.1 advance in New Orders.</li><li>Treasury prices are nevertheless higher, with the 10-year yield lower by 1.7 basis points to 2.348%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.35%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-0.7%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247182\" data-linked=\"Yields dip despite strong economic news\" data-tweet=\"$TLT $TBT $TMV - Yields dip despite strong economic news https://seekingalpha.com/news/3247182-yields-dip-despite-strong-economic-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3247182-yields-dip-despite-strong-economic-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247179\" data-ts=\"1488294829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247179-relief-rally-for-hertz-global\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relief rally for Hertz Global</a></h4><ul> <li>Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+7.3%</font>) trades higher despite missing estimates with its Q4 report.</li> <li>Today's gain may be a relief rally as Hertz traded very weak in February ahead of the report.</li> <li>MKM Partners says the read on pricing from Hertz was better than feared, while Deutsche Bank agrees that the quarter could have been worse (source: Bloomberg).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3246874-hertz-global-holdings-misses-0_16-misses-revenue\" target=\"_blank\">Hertz Global Holdings misses by $0.16, misses on revenue</a> (Feb. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247179\" data-linked=\"Relief rally for Hertz Global\" data-tweet=\"$HTZ - Relief rally for Hertz Global https://seekingalpha.com/news/3247179-relief-rally-for-hertz-global?source=tweet\" data-url=\"https://seekingalpha.com/news/3247179-relief-rally-for-hertz-global\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247178\" data-ts=\"1488294456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESND\" target=\"_blank\">ESND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247178-essendant-slides-after-surprise-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Essendant slides after surprise Q4 loss</a></h4><ul> <li>Essendant (NASDAQ:<a href='https://seekingalpha.com/symbol/ESND' title='Essendant'>ESND</a>) is in freefall after Q4 results disappoint.</li> <li>The company reported a loss of $0.02 when analysts expected a cozy profit of $0.28 per share.</li> <li>Sidoti lowers its rating on Essendant to Neutral from Buy after taking in the weak report.</li> <li>Shares of Esssendant traded as low as $15.56 today vs. a 52-week range of $14.72 to $34.99.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246885-essendant-misses-0_30-misses-revenue\" target=\"_blank\">Essendant misses by $0.30, misses on revenue</a> (Feb. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3247178\" data-linked=\"Essendant slides after surprise Q4 loss\" data-tweet=\"$ESND - Essendant slides after surprise Q4 loss https://seekingalpha.com/news/3247178-essendant-slides-after-surprise-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3247178-essendant-slides-after-surprise-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247171\" data-ts=\"1488293964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIFE\" target=\"_blank\">LIFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247171-resolaris-orphan-drug-for-limb-girdle-muscular-dystrophy-atyr-up-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Resolaris an Orphan Drug for limb girdle muscular dystrophy; aTyr up 19%</a></h4><ul><li>Thinly traded micro cap aTyr Pharma (<a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+18.8%</font>) jumps on a 7x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16755550-atyr-pharma-receives-u-s-fda-orphan-drug-designation-treatment-limb-girdle-muscular-dystrophy\" target=\"_blank\">announcement </a>that the FDA has designated Resolaris an Orphan Drug for the treatment of <a href=\"https://www.mda.org/disease/limb-girdle-muscular-dystrophy\" target=\"_blank\">limb girdle muscular dystrophy</a> &#40;LGMD&#41;, a rare genetic disorder affecting the voluntary muscles primarily around the hips and shoulders.</li><li>Among the benefits of Orphan Drug status is a seven-year period of market exclusivity for the indication, if approved.</li><li><a href=\"http://www.atyrpharma.com/programs/resolaris/\" target=\"_blank\">Resolaris&nbsp;</a>is an intravenous protein therapeutic derived from naturally occurring protein released by human skeletal muscle cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247171\" data-linked=\"Resolaris an Orphan Drug for limb girdle muscular dystrophy; aTyr up 19%\" data-tweet=\"$LIFE - Resolaris an Orphan Drug for limb girdle muscular dystrophy; aTyr up 19% https://seekingalpha.com/news/3247171-resolaris-orphan-drug-for-limb-girdle-muscular-dystrophy-atyr-up-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3247171-resolaris-orphan-drug-for-limb-girdle-muscular-dystrophy-atyr-up-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247174\" data-ts=\"1488293899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247174-bhp-ceo-says-bloody-awful-trump-trade-policies-threaten-global-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP CEO says &quot;bloody awful&quot; Trump trade policies threaten global growth</a></h4><ul>     <li>BHP&nbsp;Billiton (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-2.7%</font>)&nbsp;CEO&nbsp;Andrew Mackenzie reiterates his warnings that protectionist U.S. policies under Pres. Trump would threaten global growth, saying the consequences of restricting free trade would be &ldquo;<a href=\"https://www.bloomberg.com/news/articles/2017-02-27/bhp-is-very-anxious-that-u-s-protectionism-could-blunt-growth\" target=\"_blank\">bloody awful</a>.&rdquo;</li>     <li>Global long-term growth is ~3% but needs to be 4% to get more people out of poverty, &ldquo;and that won&rsquo;t happen under a protectionist regime and protectionist leadership in the U.S,\" Mackenzie tells Bloomberg.</li><li>Separately, BHP's VP of petroleum marketing Michiel Hovers says the <a href=\"http://www.smh.com.au/business/energy/low-oil-prices-set-to-recede-bhp-warns-amid-sluggish-output-gains-20170227-gums9j.html\" target=\"_blank\">oil market is rebalancing</a>, and forecasts that declining production from existing oilfields will more than offset low  demand growth, resulting in the present oversupply evaporating  over the  year ahead.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247174\" data-linked=\"BHP CEO says &quot;bloody awful&quot; Trump trade policies threaten global growth\" data-tweet=\"$BHP - BHP CEO says &quot;bloody awful&quot; Trump trade policies threaten global growth https://seekingalpha.com/news/3247174-bhp-ceo-says-bloody-awful-trump-trade-policies-threaten-global-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3247174-bhp-ceo-says-bloody-awful-trump-trade-policies-threaten-global-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247172\" data-ts=\"1488293868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROX\" target=\"_blank\">ROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247172-castle-brands-skyrockets-after-ginger-beer-deal-wal-mart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Castle Brands skyrockets after ginger beer deal with Wal-Mart</a></h4><ul> <li>Shares of Castle Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a>) are <font color='green'>up 81%</font> in early trading to carve out a new 52-week high.</li> <li>The rally can be summed up in one word: Wal-Mart.</li> <li>Castle Brands announced this morning that it will now supply the retail giant with Goslings Stormy Ginger Beer and Goslings Stormy Diet Ginger Beer at all of its U.S. stores.</li><li>The ginger beer will be available at Wal-Mart stores in the U.S. next month</li> <li>Source: <a href=\"https://seekingalpha.com/pr/16755531-castle-brands-announces-national-supply-agreement-walmart\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3247172\" data-linked=\"Castle Brands skyrockets after ginger beer deal with Wal-Mart\" data-tweet=\"$ROX - Castle Brands skyrockets after ginger beer deal with Wal-Mart https://seekingalpha.com/news/3247172-castle-brands-skyrockets-after-ginger-beer-deal-wal-mart?source=tweet\" data-url=\"https://seekingalpha.com/news/3247172-castle-brands-skyrockets-after-ginger-beer-deal-wal-mart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247160\" data-ts=\"1488292875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247160-workdayminus-6_3-post-earnings-citi-downgrades-to-sell-removal-of-billings-guidance-under\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday -6.3% post-earnings; Citi downgrades to Sell, removal of billings guidance under consideration</a></h4><ul><li>Amid several target increases (<a href=\"http://www.streetinsider.com/Analyst+Comments/Workday+%28WDAY%29+PT+Raised+to+%2497+at+BTIG/12601703.html\" target=\"_blank\">BTIG</a>&nbsp;from $88 to $97 [Buy],&nbsp;<a href=\"http://www.streetinsider.com/Analyst+PT+Change/Workday+%28WDAY%29+PT+Raised+to+%2495+at+Oppenheimer/12602981.html\" target=\"_blank\">Oppenheimer &amp; Co.</a>&nbsp;from $88 to $95 [Outperform],&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/Workday+%28WDAY%29+PT+Raised+to+%2491+at+Wedbush+Following+4Q+Report/12602532.html\" target=\"_blank\">Wedbush Securities</a> from $86 to $91 [Neutral],&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/Workday+%28WDAY%29+PT+Raised+to+%2483+at+Cowen/12601275.html\" target=\"_blank\">Cowen and Company</a>&nbsp;from $73 to $83 [Market Perform])&nbsp;subsequent Workday's Q4 2017 reporting, Citi <a href=\"http://www.streetinsider.com/Analyst+Comments/Citi+Downgrades+Workday+%28WDAY%29+to+Sell/12602141.html\" target=\"_blank\">analyst Walter&nbsp;Pritchard</a>&nbsp;lowers from Neutral, noting removal of a historically-provided annual billings guidance metric due to company's adoption of ASC606 (<a href=\"https://seekingalpha.com/article/4050269-workdays-wday-ceo-aneel-bhusri-q4-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call transcript</a>) as well as uncertainty over whether momentum has truly accelerated beyond a turnaround of certain Q3 challenges.</li><li>Further: \"The HCM market remains competitive with ORCL and SAP competing aggressively and in financials, the core (large $) opportunity appears pushed out, partially mitigated by success in the planning market (also competitive). Our numbers are largely unchanged and we don&rsquo;t believe we can stretch valuation further with strong growth stock performance YTD.\"</li><li>Workday(NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) $84.52.</li><li>Yesterday (February 27, 2017): <a href=\"https://seekingalpha.com/news/3246878-workday-minus-2_55-percent-hours-despite-better-expected-q4-2017-results-fy-2018-revenue\" target=\"_blank\">Workday -2.55% after hours despite better-than-expected Q4 2017 results, FY 2018 revenue outlook</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3247160\" data-linked=\"Workday -6.3% post-earnings; Citi downgrades to Sell, removal of billings guidance under consideration\" data-tweet=\"$WDAY - Workday -6.3% post-earnings; Citi downgrades to Sell, removal of billings guidance under consideration https://seekingalpha.com/news/3247160-workdayminus-6_3-post-earnings-citi-downgrades-to-sell-removal-of-billings-guidance-under?source=tweet\" data-url=\"https://seekingalpha.com/news/3247160-workdayminus-6_3-post-earnings-citi-downgrades-to-sell-removal-of-billings-guidance-under\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247153\" data-ts=\"1488292149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247153-endo-revenues-up-16-non-gaap-eps-up-30-in-q4-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endo revenues up 16%; non-GAAP EPS up 30% in Q4; updates guidance</a></h4><ul><li>Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) <a href=\"https://seekingalpha.com/pr/16755266-endo-reports-fourth-quarter-full-year-2016-financial-results\" target=\"_blank\">Q4 results</a>: Revenues: $1,241.5M (+15.6%); Operating Loss: ($3,294.6M); Net Loss: ($3,333.3M); Loss Per Share: ($14.96); Non-GAAP EPS: $1.77 (+30.1%).</li><li><strong>2016 results</strong>: Revenues: $4010.3M (+22.7%); Operating Loss: ($3,471.5M) (-271.9%); Net Loss: ($3,223.8M); Loss Per Share: ($14.48); Non-GAAP EPS: $4.73 (+2.2%); Quick Assets: $517.3M (+90.0%); CF Ops: $524.4M.</li><li><strong>2017 Guidance</strong>: Total revenues: $3.45B - 3.60B; GAAP EPS: $0.04 - 0.34; Non-GAAP EPS: $3.45 - 3.75; Adjusted EBITDA: $1.50B - 1.58B.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247153\" data-linked=\"Endo revenues up 16%; non-GAAP EPS up 30% in Q4; updates guidance\" data-tweet=\"$ENDP - Endo revenues up 16%; non-GAAP EPS up 30% in Q4; updates guidance https://seekingalpha.com/news/3247153-endo-revenues-up-16-non-gaap-eps-up-30-in-q4-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3247153-endo-revenues-up-16-non-gaap-eps-up-30-in-q4-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247152\" data-ts=\"1488292038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247152-corbus-pharma-to-net-27m-via-direct-placement-of-stock-shares-down-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corbus Pharma to net $27M via direct placement of stock; shares down 12% premarket</a></h4><ul><li>Corbus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) is off&nbsp;<font color='red'>12%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16755908-corbus-pharmaceuticals-announces-27_2-million-registered-direct-offering\" target=\"_blank\">agreement </a>to sell 3,887,815 common shares at $7 via a direct offering. Net proceeds of $27.1M will fund the continued clinical development of JBT-101 and general corporate purposes. Closing date is February 28.</li><li>Yesterday's close was $9.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247152\" data-linked=\"Corbus Pharma to net $27M via direct placement of stock; shares down 12% premarket\" data-tweet=\"$CRBP - Corbus Pharma to net $27M via direct placement of stock; shares down 12% premarket https://seekingalpha.com/news/3247152-corbus-pharma-to-net-27m-via-direct-placement-of-stock-shares-down-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3247152-corbus-pharma-to-net-27m-via-direct-placement-of-stock-shares-down-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247151\" data-ts=\"1488291763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247151-brokers-tumble-fee-war-escalates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brokers tumble as fee war escalates</a></h4><ul><li>Fidelity drops a big one, <a href=\"https://www.bloomberg.com/news/articles/2017-02-28/fidelity-slashes-commissions-in-the-latest-salvo-in-the-fee-wars\" target=\"_blank\">cutting online commissions</a> for U.S. stocks and ETFs to $4.95 from $7.95. Options prices will be cut to $0.65 per contract from $0.75.</li><li>The new commission rate is 50% lower than that at E*Trade (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>) and TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>), and 28% lower than Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>) - which recently cut its fee.</li><li>Alongside, Fidelity is cutting rates on margin players.</li><li>ETFC&nbsp;<font color='red'>-5.4%</font>, SCHW&nbsp;<font color='red'>-3.3%</font>, AMTD&nbsp;<font color='red'>-6%</font>, <a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a><font color='red'> -2.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3247151\" data-linked=\"Brokers tumble as fee war escalates\" data-tweet=\"$ETFC $ETFC $AMTD - Brokers tumble as fee war escalates https://seekingalpha.com/news/3247151-brokers-tumble-fee-war-escalates?source=tweet\" data-url=\"https://seekingalpha.com/news/3247151-brokers-tumble-fee-war-escalates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247148\" data-ts=\"1488291442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KITE\" target=\"_blank\">KITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247148-kites-lead-product-candidate-successful-in-late-stage-blood-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kite&#39;s lead product candidate successful in late-stage blood cancer study</a></h4><ul><li>Kite Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a>) <a href=\"https://seekingalpha.com/pr/16755325-kite-announces-positive-topline-primary-results-axicabtagene-ciloleucel-first-pivotal-car-t\" target=\"_blank\">announces </a>positive results from its Phase 3 ZUMA-1 study assessing lead product candidate axicabtagene ciloleucel (formerly KTE-C19) in patients with chemo-resistant aggressive B-cell non-Hodgkin lymphoma &#40;NHL&#41;. The trial met its primary endpoint demonstrating an 82% objective response rate after a single infusion of axicabtagene ciloleucel (p&lt;0.0001).</li><li>The complete response rate was 36% at month 6. Median overall survival has not been reached (median follow-up period of 8.7 months).</li><li>The most common grade 3 (severe) or higher adverse events were anemia (43%), neutropenia (39%), decreased neutrophil count (32%), febrile neutropenia (31%), decreased white blood cell count (29%), thrombocytopenia (24%), encephalopathy (21%) and decreased lymphocyte count (20%).</li><li>The company plans to complete its rolling BLA submission in the U.S. by the end of next month. Its marketing application in Europe for three blood cancers (DLBCL, PMBCL, TFL) will be submitted this year.</li><li>Axicabtagene ciloleucel is an investigational therapy in which the patient's T cells are genetically modified to express a CAR (chimeric antigen receptor) that targets the CD19 antigen, a protein expressed on the surface of B-cell lymphoma and leukemia cells. This enables the T cells to locate and kill the cancer cells. If approved, it will be the first CAR T therapy commercially available in the U.S.</li><li>Nasdaq has not reported any premarket trades this morning.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247148\" data-linked=\"Kite&#39;s lead product candidate successful in late-stage blood cancer study\" data-tweet=\"$KITE - Kite&#39;s lead product candidate successful in late-stage blood cancer study https://seekingalpha.com/news/3247148-kites-lead-product-candidate-successful-in-late-stage-blood-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3247148-kites-lead-product-candidate-successful-in-late-stage-blood-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247147\" data-ts=\"1488291410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247147-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LIFE' title='aTyr Pharma'>LIFE</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SBY' title='Silver Bay Realty Trust Corp.'>SBY</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> INCR <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FRGI' title='Fiesta Restaurant Group, Inc.'>FRGI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ZTO' title='ZTO Express'>ZTO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a> <font color='red'>-6%</font>. VRX <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3247147\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$LIFE $SBY $DRYS - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3247147-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3247147-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247142\" data-ts=\"1488291061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CY\" target=\"_blank\">CY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247142-cypress-semiplus-4-on-iphone-8-supply-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cypress Semi +4%; on iPhone 8 supply talk</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls/status/836568729806909442\" target=\"_blank\">via Notable Calls</a></li><li>According to Craig-Hallum, Cypress Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a>) will be supplying the iPhone 8 type C USB. The team there sees EPS as closer to $1 (vs. consensus $0.70) thanks to this.</li><li>Shares&nbsp;<font color='green'>+4%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3247142\" data-linked=\"Cypress Semi +4%; on iPhone 8 supply talk\" data-tweet=\"$CY - Cypress Semi +4%; on iPhone 8 supply talk https://seekingalpha.com/news/3247142-cypress-semiplus-4-on-iphone-8-supply-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3247142-cypress-semiplus-4-on-iphone-8-supply-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247135\" data-ts=\"1488290672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247135-amarin-revenues-up-59-in-fy16-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin revenues up 59% in FY16; shares up 3% premarket</a></h4><ul><li>Amarin (<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a>) <a href=\"https://seekingalpha.com/pr/16755227-amarin-reports-record-fourth-quarter-full-year-2016-financial-results-provides-update\" target=\"_blank\">Q4 results</a>: Revenues: $38.7M (+45.5%); Operating Loss: ($12.9M) (+30.6%); Net Loss: ($27.5M) (-25.6%); Loss Per Share: ($0.10) (+16.7%).</li><li><strong>2016 results</strong>: Revenues: $130.1M (+59.0%); Operating Loss: ($65.6M) (+33.2%); Net Loss: ($86.4M) (+25.0%); Loss Per Share: ($0.41) (+50.6%); Quick Assets: $98.3M (-8.1%).</li><li>No guidance given.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247135\" data-linked=\"Amarin revenues up 59% in FY16; shares up 3% premarket\" data-tweet=\"$AMRN - Amarin revenues up 59% in FY16; shares up 3% premarket https://seekingalpha.com/news/3247135-amarin-revenues-up-59-in-fy16-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3247135-amarin-revenues-up-59-in-fy16-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3247130\" data-ts=\"1488290107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPHT\" target=\"_blank\">OPHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3247130-ophthotech-q4-revenues-up-11-loss-share-widens-82-shares-ease-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ophthotech Q4 revenues up 11%; loss/share widens 82%; shares ease 8% premarket</a></h4><ul><li>Ophthotech (NASDAQ:<a href='https://seekingalpha.com/symbol/OPHT' title='Ophthotech Corporation'>OPHT</a>) <a href=\"https://seekingalpha.com/pr/16755328-ophthotech-reports-fourth-quarter-full-year-2016-financial-operating-results\" target=\"_blank\">Q4 results</a> ($M): Collaboration Revenue: 5.3 (+11.3%).</li><li>Net Loss: (66.3) (-85.9%); Loss/Share: (1.86) (-82.4%).</li><li>Company says evaluation of strategic alternatives is ongoing. Options include obtaining the rights to additional products, product candidates and technologies to treat ophthalmic diseases, especially those related to the back of the eye. As part of implementing its strategic plan, Glenn Sblendorio has assumed the role of President while continuing to serve as CFO and Keith Westby has been promoted to SVP and Chief Operating Officer.</li><li>Shares are down&nbsp;<font color='red'>8%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3247130\" data-linked=\"Ophthotech Q4 revenues up 11%; loss/share widens 82%; shares ease 8% premarket\" data-tweet=\"$OPHT $ISEE - Ophthotech Q4 revenues up 11%; loss/share widens 82%; shares ease 8% premarket https://seekingalpha.com/news/3247130-ophthotech-q4-revenues-up-11-loss-share-widens-82-shares-ease-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3247130-ophthotech-q4-revenues-up-11-loss-share-widens-82-shares-ease-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}